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IDENTIFICATION AND EXPRESSION OF A NOVEL HOMEOBOX GENE IN A 
MEGAKARYOCYTIC LEUKEMIA CELL LINE. Leonard J. Landesberg and Kenichi 
Takeshita. Section of Hematology, Department of Internal Medicine, Yale University 
School of Medicine, New Haven, CT. 
The homeobox-containing genes encode transcription factors responsible for 
regulating cytodifferentiation and developmental events including those of hematopoiesis. 
Utilizing a set of degenerate primers designed to detect different types of divergent 
homeodomains by reverse transcriptase-PCR (RT-PCR), a novel homeobox gene 
(preliminarily named PAX-TS) has been identified in a megakaryocytic cell line (TS 9;22) 
derived from a patient in chronic myelogenous leukemia (CML) blast crisis. The RNase- 
protection assay against five leukemia cell lines confirmed that PAX-TS is only expressed 
TS 9;22. Sequence analysis demonstrates 100% amino acid homology to the homeobox of 
the recently described Cart-1 gene, which is expressed exclusively in rat chondrocytic cells, 
and 69% homology to PAX-3, a member of the paired-type homeobox-containing genes. 
Expression analysis by RT-PCR with Southern blot of other organs and tissues indicates 
expression in normal human bone marrow, in the day 11 mouse embryo, and in the adult 
rat kidney, suggesting that PAX-TS is either the same gene as Cart-1 or is a new gene 
which is expressed during normal embryogenesis, hematopoiesis, and in adult tissues. 
Similar studies, using chronic-phase and blast-crisis bone marrow total RNA samples from 
the CML patient whose bone marrow was used to establish the TS 9;22 cell line failed to 
demonstrate PAX-TS expression. In summary, we have isolated a new homeobox gene, 
PAX-TS, and conclude that 1) in TS 9;22, PAX-TS is expressed either ectopically or in the 
small subset of bone marrow cells which may have been preferentially selected in the 






Cell differentiation is governed by strict molecular controls. During 
embryogenesis, a single celled zygote divides and differentiates into the cell groups 
destined to assume the characteristics of all tissue types. In many adult organs, such as the 
bone marrow and gastrointestinal tract, multipotent stem cell populations differentiate to 
provide a source of cells for mature, functioning organs. The mechanisms responsible for 
the precise organization and control of these events at the cellular and molecular levels 
remain undiscovered. When the events of differentiation are effectively carried out, the 
result is a phenotypically normal organism or a normal functioning adult organ. However, 
when these mechanisms go awry, the result may be a phenotypically abnormal or nonviable 
organism, an inappropriately functioning organ system, or the production of a cell 
population (i.e. a tumor) whose growth and differentiation characteristics are out of 
control. 
Normal hematopoiesis 
Hematopoiesis, the formation of white and red cells and platelets in the bone 
marrow, is an excellent model for the study of both normal and abnormal cell 
differentiation. It may be studied within a single compartment (the bone marrow) and the 
end products of differentiation are relatively few in number and need not conform to the 
defined spatial organization of other tissues. Many clinically important entities, such as the 
leukemias and aplastic anemias, represent abnormalities in hematopoiesis. 
Hematopoiesis serves to continuously provide an organism with the full 
complement of functional cells which make up the peripheral blood. These cells include 
erythrocytes, neutrophils, eosinophils, basophils, lymphocytes, monocyte/macrophages, 
and the megakaryocyte-derived platelets. It is an extraordinarily flexible system with a 
capacity for the production of 2.4 million red blood cells per second in a normal adult, and 
with the ability to effect rapid and controlled fluctuations in specific blood populations in 
response to stresses such as infection, hemorrhage, and allergic conditions (1). With the 
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advent of newer biochemical and molecular techniques, many important hematopoietic 
humoral growth factors and cell receptors have been discovered. These factors have been 
found to directly influence the proliferation and differentiation of bone marrow elements. 
However, the control and coordination of hematopoiesis at the molecular level remains 
largely unknown. 
The current view of hematopoiesis is reflected by the stem cell model. This model 
underlies our current understanding of both normal hematopoiesis and pathologic 
hematologic disease states. In this system, all hematopoietic cells derive from a relatively 
small pool (estimated at approximately 1 out of every 10^ nucleated bone marrow cells) of 
undifferentiated, pluripotent hematopoietic stem cells. These cells would have the ability to 
differentiate along any of the lineages of mature peripheral blood elements and for self¬ 
renewal in order to replenish the source of future hematopoiesis (2). Under the rubric of the 
stem cell model, hematopoiesis is divided into three major steps: 1) commitment, in which 
the pluripotent stem cell is somehow instructed to become limited to a specific subset of 
hematopoietic lineage possibilities (e.g. erythroid), 2) proliferation, in which committed, 
progenitor cells divide and increase their numbers in response to both humoral 
hematopoietic growth factors and specific intracellular transcription factors, and 3) 
maturation, in which each committed progenitor cell assumes the phenotypic properties of 
the lineage to which it has committed (Figure 1). 
Evidence of a pluripotent stem cell was demonstrated in experiments involving bone 
marrow transplantation into mice whose marrow had been ablated by irradiation. The 
transplanted bone marrow rescued these mice (3) and replaced the hematopoietic process. 
It was also noted that the spleens of these mice contained large colonies of maturing 
hematopoietic cells (CFU-S) reflecting all the different lineage possibilities. When these 
colonies were extracted and injected into another irradiated mouse, they, in turn, were able 
to reconstitute hematopoiesis (4). Subsequent chromosomal analysis proved that the CFU- 
S-derived colonies were clonal in origin, suggesting that the cells in these colonies derived 
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from a pluripotent stem cell (5, 6). When the mitotic activity of the CFU-S-derived 
colonies was analyzed, it was shown that only 5% of the cells in a single colony were 
actively dividing. This data supported the hypothesis that a small subset of quiescent stem 
cells divided infrequently in order replenish the supply of multilineage precursors (7). 
As stated above, during the process of commitment, the pluripotent stem cell is 
somehow restricted into assuming the fate of one cell lineage. At this stage, the cells are 
no longer pluripotent. They are now only multipotent and have a limited capacity for 
proliferation; they probably divide only during the process of their own differentiation in 
response to growth factors (Figure 1). The first stage of commitment involves restriction 
to either a lymphoid or myeloid lineage (8). These multipotential progenitor cells can be 
detected experimentally as colony forming units (CFUs) (such as CFU-L and CFU- 
GEMM, which includes the granulocyte, erythrocyte, eosinophil, basophil, monocyte, and 
megakaryocyte lineages) in the colony assay. In this procedure, bone marrow progenitor 
cells of the desired lineage(s) are detected by colony formation in a semi-solid medium, 
such as methylcellulose in response to a specific growth factor(s). Colonies (50-100 cells) 
or bursts (>100 cells) are clonal in origin and derive from a single CFU (or BFU) 
progenitor cell. Those cells which are unresponsive to the given growth factor are 
nonviable (9). 
The multipotential progenitor cells further differentiate into unipotential progenitor 
cells of the specific lineages. These unipotent progenitor cells which can also be detected in 
the colony assay (CFU- E, MK, G, M, Eo, Ba, B, T and BFU-E) (8) (see Figure 1). 
Interestingly, while the action of the humoral growth factors is required for differentiation, 
the lineage choices made by progenitor cells appear to be random. Ogawa et al. showed 
that when CFU-GEMM progenitor cells were exposed to GM-CSF (which permits terminal 
differentiation along granulocytic, monocytic, eosinophilic, erythroid, and megakaryocytic 
lineages) in vitro, the commitment to a specific lineage was made randomly. Even daughter 




Although hematopoietic cells look morphologically alike at the progenitor stage, it is 
possible to isolate lineage-committed populations based upon the presence or absence of 
certain surface antigens known as "cluster determinants" (CD). Over the course of 
differentiation, the pattern of CD expression on the cell surface changes. These proteins 
are defined for the most part by monoclonal antibodies raised against human hematopoietic 
cells in mice and have been used to classify and fractionate cells of various lineages. For 
example, CD33 is present on the granulocytic, erythroid, monocytic and megakaryocytic 
progenitor cells. CD 13 is a marker present on granulocytic and monocytic progenitors and 
CD 14 is specific for mature monocytes. CD34 is a marker of primitive hematopoietic cells 
including the pluripotent stem cells and most progenitors (11). 
It is currently thought that pluripotent stem cells are CD34+HLA-DR'CD33"CD38". 
CD34+HLA-DR' bone marrow cells contain the pluripotent stem cells capable of 
reconstituting lethally irradiated bone marrow (12, 13). The CD34+ cell fraction may also 
be further subdivided to isolate committed progenitors (CD34+/CD38+) from the more 
primitive hematopoietic cells (CD34+/CD38") (Figure 2) (14). 
Humoral factors 
Hematopoietic cell proliferation and terminal differentiation into the mature 
phenotype are controlled by the actions of humoral growth factors and as yet undiscovered 
transcriptional regulators. The human hematopoietic growth factors include a group of at 
least 12 glycoprotein hormones. The major growth factors, or colony stimulating factors 
(CSF), are summarized in Table 1. These include: granulocyte-macrophage CSF (GM- 
CSF), granulocyte CSF (G-CSF), macrophage CSF (M-CSF), erythropoietin (Epo), and 
the interleukins (IL-1,3,4, 5, 6, 7, 8, 9 (IL-3 is also known as multi-CSF)). They all are 
relatively small, acidic glycoproteins (18,000-90,000kD) and are active at extremely low 
concentrations (picomolar range in vitro). In general, they are not lineage specific, and are 
produced by several different cell types. In addition to their proliferative effects, these 
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proteins also are important for the maintenance of hematopoietic progenitor cell viability 
(1). 
The four "classical" colony stimulating factors, GM-CSF, G-CSF, M-CSF, and 
IL-3 also act on mature blood elements such as granulocytes and monocytes in order to 
promote the functional activities of these cells. They prolong cell survival, induce 
membrane receptor changes, prime for oxidative bursts, are chemotactic, and enhance the 
ability for phagocytosis, bacterial cell kill, and cytotoxicity. Among the CSFs, GM-CSF 
acts on eosinophils, neutrophils and monocyte/macrophages; IL-3 acts on eosinophils and 
monocytes; G-CSF acts on neutrophils; M-CSF acts on monocyte/macrophages. These 
CSFs are complemented by erythropoietin (Epo) which supports the proliferation and 
differentiation of late erythroid progenitors (CFU-E) in vitro. Growth of earlier 
progenitors (BFU-E) depends on the burst promoting activity of IL-3 and GM-CSF. Epo is 
required later for proliferation and hemoglobinization (Table 2) (15). 
It is important to note that, although the CSFs bear little structural resemblance to 
each other, the growth factor receptors do share significant homology in the amino acid 
sequence. In the case of multi-subunit receptors, they share one of the receptor subunits . 
They are grouped together in the cytokine receptor family which includes the 
erythropoietin, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, G-CSF, and GM-CSF receptors (16). 
This similarity at the receptor level is important for understanding the mechanisms by 
which growth factor stimulation is transmitted to the cell's transcriptional regulatory 
apparatus which, in turn, controls cell proliferation and/or differentiation. 
Several types of receptor-mediated systems are known to function in cell signaling. 
These include: 1) the neurotransmitter-gated ion channels which open or close briefly to 
alter the electrical excitability of the cell, 2) the G-protein linked receptors which directly 
activate or deactivate plasma-membrane-bound enzymes or ion channels by hydrolyzing 
their bound GTP, 3) the catalytic receptors which are mainly tyrosine kinases that directly 
phosphorylate specific target cell proteins on tyrosine residues, and 4) receptors which 
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activate intracellular tyrosine kinases (17). 
The signal-transducing events that are activated by stimulation of hematopoietic 
growth factor receptors appear to involve tyrosine phosphorylation. It has been shown that 
some hematopoietic cell lines containing constitutively activated tyrosine kinases do not 
require CSFs for survival and growth (18, 19). Although the cytokine receptors do not 
contain a consensus tyrosine kinase catalytic domain, it has been noted that tyrosine 
phosphorylation is rapidly induced upon treatment with several growth factors. For 
example, there is data that IL-3-mediated cell activation occurs via tyrosine kinase activation 
(20). Also, studies of the erythropoietin/erythropoietin receptor interaction have 
demonstrated the induction of phosphorylation and kinase activity of the c-fps/fes proto¬ 
oncogene product in Epo-responsive cells (21). Mutagenesis experiments have 
demonstrated that disruption of specific regions of the erythropoietin receptor leads to 
impairment of the induction of tyrosine kinase activity, although the Epo-receptor itself has 
no kinase activity (22). Therefore, although the CSFs vary in structure, the homology of 
the cytokine receptors has a functional correlate. The binding of cytokines to their receptor 
results in intracellular biochemical changes, such as the activation of tyrosine kinase 
phosphorylation of proteins. Recent reports suggest that some of these tyrosine kinases 
may phosphorylate transcription factors (23, 24, 25). These studies provide a valuable link 
between the extracellular actions of the CSFs and the intracellular events which ultimately 
determine cell proliferation and differentiation. 
It may be generalized that hematopoiesis involves the regulation of two primary 
processes: 1) the intracellular events which result in changes in gene expression and the 
extracellular signals which alter these events. The external signals are, in part, transduced 
via cytokine receptors, which activate biochemical changes such as phosphorylation. In 
this signal transduction pathway, transcription factors affecting gene expression could be 
modified by phosphorylation. Thus, transcription factors are an important participant in the 
signal transduction cascade. 
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Transcription factors in hematopoiesis 
Gene transcription, the process of copying a DNA template into messenger RNA, 
is performed in eukaryotes such as humans by RNA polymerase II. In addition to the 
binding of RNA polymerase to DNA at specific initiation sites, each gene contains 
regulatory sequences which are able to modify expression in response to the needs of the 
cell. These sequences are called promoters, enhancers, and silencers and have the capacity 
to bind specific regulatory proteins which act as transcription factors. The protein 
structures and the mechanisms by which several of these factors bind DNA are now 
known. It is possible to group these proteins into families which share common amino 
acid motifs. These motifs may either directly affect DNA-binding or indirectly affect it by 
enabling monomeric proteins to dimerize into an active form. Examples include the helix- 
tum-helix, helix-loop-helix, leucine zipper, and Zn-finger families. 
The helix-turn-helix group of proteins is characterized by three contiguous alpha 
helical regions separated by single short turns. They dimerize and bind to DNA with an 
alpha helix from each monomer occupying the major groove of the DNA double helix. The 
leucine-zipper and helix-loop-helix "amphipathic" transcription factors are believed to also 
function as dimers. Specific secondary structural features of the protein monomers (e.g. 
sequentially spaced leucine residues) enable their assembly and hence, the proper 
association of the DNA-binding domains with the DNA. The zinc-finger proteins require 
zinc (Zn) for DNA-binding activity. Sequence analysis demonstrates that these proteins 
contain cysteine and histidine residues at fixed intervals along the amino acid chain. 
Cysteine and histidine are known ligands for Zn in proteins. A putative structure involves 
Zn ions interacting with the cysteine and histidine residues in order to support the folded 
DNA-binding domain in a "finger-like" formation (26). 
Several transcription factors have been identified whose patterns of expression 
suggest that they are involved in hematopoiesis. Some of these genes, such as Id and c- 
myb are believed to function as general transcription factors with important effects on 
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hematopoiesis. C-myb is a DNA-binding, cellular proto-oncogene whose expression has 
been reported in a number of human malignancies such as colon, lung, and breast 
carcinoma. In addition, it has been isolated from several non-human retroviruses involved 
in hematologic malignancies. While it appears that c-myb is a general transcription factor 
and is expressed in many tissues during embryogenesis as well as during cellular 
proliferation in general, Mucenski et al. reported that this gene is required for normal 
hematopoiesis. By disrupting c-myb in chimeric mice by homologous recombination in 
mouse embryonic stem cells and then interbreeding to select for homozygous c-myb- 
progeny, it was shown that the c-myb- mice became severely anemic during gestation. 
Embryonic erythropoiesis occurring in the yolk sac was normal, but the subsequent adult- 
type erythropoiesis occurring in the liver was severely impaired (27). 
The Id gene codes for a helix-loop-helix protein which acts as a negative 
transcription factor. Id lacks a DNA-binding domain but is able to heterodimerize with 
other helix-loop-helix transcription factors and thus, inactivate them. Kreider et al. studied 
Id expression during myeloid differentiation. It is not expressed in lymphoid or erythroid 
cells. They noted a decrease in the expression of Id as a myeloid precursor cell line (32D 
cl3(G)) was induced to differentiate with G-CSF. When Id was constitutively expressed it 
blocked the ability of 32D c 13(G) to differentiate. However, Id expression is not limited to 
hematopoietic cells (28). Thus, Id may act as a negative regulator by heterodimerization and 
blockade of the action of other helix-loop-helix transcription factors during myelopoiesis 
and possibly other tissue types. 
Among the transcription factors whose expression patterns are more restricted to 
hematopoietic cells, GAT A-1 andtal-1 have been especially well-studied. GATA-1 is a 
Zn-finger transcription factor which binds to a consensus DNA element in the regulatory 
regions of the alpha- and beta-globin gene clusters and other erythroid cell-specific genes 
(29, 30, 31,32, 33, 34). It is also expressed in megakaryocytes and mast cells but, 
importantly, not in other blood cell lineages or in non-hematopoietic cells (35, 36, 37). 
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Several studies have shown that GATA-1 is involved in erythroid cell maturation. Pevny et 
al. showed that when GATA-1 was disrupted by homologous recombination in a murine 
embryonic stem cell line and introduced into chimeric mice, the progeny mutant cells 
contributed to all cell tissue types except erythrocytes. This study proved that GATA-1 
was required for normal erythropoiesis (38). 
The tal-1 gene, also known as SCL, has also been implicated as a hematopoietic 
transcription factor. In normal hematopoiesis, tal-1 has been shown to be expressed in 
early myeloid, erythroid, megakaryocytic, and mast cell lines, but not in the lymphocytic 
lineages. Among the non-hematopoietic tissues, tal-1 is only expressed in the developing 
brain, tal-1 is a member of the family of amphipathic helix-loop-helix transcription factors, 
(39, 40), a group which includes several genes that are clearly implicated in lymphoid 
malignancies because of their involvement in chromosomal translocations (e.g. the t(8; 14) 
translocation involving the MYC gene in Burkitt's lymphoma and the t( 1; 19) translocation 
resulting in the E2A-PBX1 hybrid in B-cell ALL). Tal-1 is deregulated via chromosomal 
derangements (either translocations or deletions) in 30% of acute T-cell leukemia (T-ALL). 
In these cases, tal-1 expression is coupled to the regulatory regions of genes which are 
expressed in normal T-cells. Somehow, tal-1 overexpression changes the course of 
hematopoiesis along an abnormal lymphoid lineage (39, 41,42, 43). 
A recent study has demonstrated that both tal-1 and GATA-1 are downregulated 
when the K562 human erythroleukemia cell line is induced to differentiate toward a 
macrophage-like morphology by treatment with hexamethylene bisacetamide (HMBA). 
Northern blot analysis also demonstrated a down-regulation of both the alpha- and B-globin 
genes accompanying HMBA-induced differentiation away from an erythroid phenotype 
(44). A prior study using antisense disruption of tal-1 in the same cell line, K562, showed 
that this gene is also required for cell proliferation (45). 
Mouthon et al. have performed a similar study of GATA-1 and tal-1 in which their 
expression was analyzed in normal hematopoietic cells rather than in leukemic cell lines. 

-10- 
They showed that tal-1 and GATA-1 were coexpressed in the committed progenitor 
(CD34+/CD38+) cell fraction whereas they were undetectable in the more primitive 
(CD34+/CD38-) cell fraction (see Figure 2). When GATA-1 and tal-1 expression were 
studied by in situ hybridization to CD34+, BFU-E-derived-colonies and cultured, 
immature megakaryocyte colonies, it was noted that both genes were coordinately 
downregulated during erythroid and megakaryocytic terminal maturation (46). 
It is evident that the activity of certain DNA-binding proteins are important for the 
regulation of normal hematopoiesis even in the presence of the appropriate growth factors. 
Some have also been implicated in certain hematologic malignancies. The expression of 
certain transcription factors such as GAT A-1 and tal-1 appear to be more restricted to 
hematopoietic and a few other cell types. These, and other as yet undiscovered genes are 
clearly essential for proliferation and maturation of mature blood elements. Further studies 
may show that they also play an vital role in the less understood process of lineage 
commitment from the pluripotent stem cell. 
The homeobox genes 
The homeobox-containing genes, a family of interrelated DNA-binding proteins, 
have also been implicated as transcription factors in the hematopoietic process (47). A 
homeotic transformation is either a duplication of an anterior/posterior body structure or the 
replacement of one body structure with another during embryogenesis. In the early 1980s 
it was found that a homeotic transformation leading to the formation of legs in place of 
antennae in the fruit fly. Drosophila melanogaster, could be explained by a mutation in a 
single gene. This gene was characterized and named Antennapedia (Antp.) (Figure 4). 
Other such mutations in Drosophila led to the discovery of a group of genes which are 
believed to control body pattern formation during embryonic development. Comparison of 
these gene sequences with Antp. demonstrated that they share a highly conserved 180-183 
nucleotide sequence named the homeobox (48, 49, 50). It was postulated that these genes 
functioned at the level of transcription in order to influence the production of effector genes 
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which determine cell type fate and tissue identity (51, 52, 53). Now known as the 
homeobox family, these genes are characterized by an evolutionarily conserved 60-61 
amino acid domain, known as the homeodomain, which was shown by X-ray 
crystallography to form a helix-turn-helix motif capable of binding to DNA (54, 55, 56) 
(Figure 3). A diagram of the Antp. homeobox and its three conserved alpha-helical regions 
is shown in Figure 4. 
The homeobox has been identified in 25 Drosophila genes which are grouped 
together in a cluster called HOM-C. The HOM-C cluster is characterized by Antp.-like 
homeoboxes and these are known as the class I homeobox genes. Although these genes 
differ considerably outside the homeobox, the homeodomain itself is remarkably similar. It 
has also been shown that these genes lie in the same order in the homeobox cluster as does 
their expression pattern along the anterior/posterior axis of the the developing insect 
embryo, suggesting a formal relationship between chromosomal architecture and 
embryogenesis (57). There are also several genes which contain homeodomains which are 
related to but are divergent from Antp. A divergent homeobox is one in which the 
sequence of the homeodomain varies greatly from Antp., but does retain certain highly 
conserved amino acid residues at the 3' end of the homeodomain, namely the amino acid 
sequence, IWFQNRR, which is extremely well conserved in almost all homeobox genes. 
These divergent genes are not necessarily confined to the HOM-C cluster and are located 
throughout the genome in the Drosophila. 
Mammalian homeobox genes 
The homeodomain has been conserved among diverse species including the 
nematodes, annelids, arthropods, plants, and vertebrates including humans (58, 59, 60, 
61). This conservation suggests an evolutionarily functional significance. As in the 
Drosophila, the mammalian body plan also appears to be governed at least in part by the 
actions of homeobox genes. Expression analysis has demonstrated activity in all 
embryonic tissues including the nervous system, the developing extremities, and the genital 
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region (62, 63, 64, 65). Recent studies with mice have revealed gross developmental 
anomalies after the homozygous deletion of individual homeobox genes. For example, 
mice with a homozygous deletion of Hox a3 died shortly after birth but presented with 
congenital absence of the thyroid, parathyroid, and thymus glands as well as with 
anomalies in the craniofacial, submaxillary and cardiac regions, suggesting a similarity to 
the human DiGeorge's syndrome (66). Similar "knock-out" experiments with other 
homeobox genes have demonstrated homeotic transformations resulting in: 1) delayed 
hindbrain neural tube closure, absence of portions cranial nerves VII, VIII, IX and X, and 
malformed inner ear and parieto-occipital bony structures with Hox al deletion (67, 68), 
and 2) transformations of thoracic skeletal structures from deletion of Hox c8 (69). These 
defects are related to the spatial patterning of the embryo rather than to single tissues, 
organs or cell types, reflecting the putative role of the homeobox genes as body plan 
organizers. 
In humans, 38 class I homeobox genes have been identified. As in Drosophila, the 
class I homeobox genes are designated because of their similarity to Antp. and are clustered 
into distinct chromosomal regions. However, in humans they are spread among four 
separate chromosomes in four clusters called HOXA, HOXB, HOXC, and HOXD located 
on chromosomes 7, 17, 12, and 2, respectively (70). See Figure 5 for the chromosomal 
organization of the human and murine class I homeobox genes. Each cluster contains 
between 9 and 11 genes which are numbered to correspond to both their linear organization 
on the chromosome and to their pattern of expression . This new nomenclature replaces a 
former system in which the human HOX clusters were numbered 1-4 with each gene 
designated by a capital letter corresponding to its order of discovery . As in the human, the 
murine equivalents (Hox) of the class I genes are clustered on four chromosomes in loci 
named Hoxa, Hoxb, Hoxc, and Hoxd and are also designated with numerical appellations 
(71, 72). On the basis of comparative amino acid sequences within the homeodomain, the 
HOX genes can be organized into 13 "paralogous" groups between the chromosomes (for 
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example HOXA4, B4, C4, and D4) (Figure 5). It is significant that the paralogues occupy 
the same positions in their respective chromosomal HOX clusters so that the linear 
organization of each cluster is the same. This paralagous relationship also corresponds to 
the members of the Drosophila HOM-C cluster (Figure 5). Based on this organization of 
paralogous clusters, a consensus of opinion holds that, over the course of the evolution of 
higher animals, these four chromosomal homeobox complexes arose from successive 
duplications and mutations of a primordial homeobox cluster (73). 
The empty gene spaces within each HOX cluster were originally left for the 
predicted paralogues which had not yet been discovered (70, 74) (Figure 5). However, 
these regions have been cloned and sequenced and do not contain any genes. The 
significance of this finding is unclear. 
In both mice and humans, as in Drosophila, the expression of homeobox genes 
within a cluster parallels the spatial patterns of embryogenesis. In mice, the anterior- 
posterior pattern of homeobox expression corresponds to the 5' to 3' position in the Hox 
cluster (62). In other words, one can define class I homeobox genes as "anterior" or 
"posterior" based on their position within the cluster, with the expression domain of the 5' 
genes being represented more anteriorly than their 3' neighbors. This spatial hierarchical 
arrangement has been demonstrated in transgenic mice when the ectopic expression of Hox 
d4 outside of its native pattern resulted in phenotypic anomalies whereby the occipital 
bones were transformed into cervical vertebrae. In essence, a normally rostral area was 
replaced by an ectopically placed caudal structure (75). In humans, it has been shown that 
retinoic acid is able to induce HOX gene expression in teratocarcinoma cells in a sequential 
manner such that expression favors the more 3' ends of each cluster (76, 77). 
The complexity of homeobox functioning is magnified by the discovery that the 
expression of single genes is modified by alternative splicing of the mRNA transcripts. In 
other words, one gene can encode several proteins. The alternative splicing products 
include transcripts with or without the homeodomain, and transcripts with varied regulatory 
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regions (78, 79, 80, 81, 82, 83) . This added dimension suggests another level of 
regulation which acts to "fine-tune" the effects of single or groups of homeobox genes. 
Divergent homeobox genes 
As in Drosophila, the human genome contains a subset of divergent homeodomain- 
containing genes which, as discussed above, do retain some highly conserved amino acid 
residues in the homeobox and are not confined within the HOX clusters. Some of these 
genes are direct homologues of the Drosophila divergent homeoboxes; others have been 
identified which have no known fruit fly equivalent. It is possible to group these divergent 
homeobox genes into families which share significant sequence homology in the first ten 
amino acids of the homeobox (84). Among these, are the evx family (related to the even- 
skipped Drosophila gene), the en family (related to the engrailed Drosophila gene), and the 
octamer family. 
Figure 4 contains a schematic representation of several of the known types of 
homeodomain-containing genes. Some divergent homeobox genes contain additional, 
conserved DNA-binding peptide domains. An unexpected finding was the ZF class of 
divergent homeobox genes which contain some combination of several Zn-finger motifs 
and extremely divergent homeodomains (85, 86). In addition to a homeodomain, the Pax 
family contains a common protein domain homologous to the Drosophila paired box. The 
paired-box motif also has DNA-binding properties (87). This family's homology lies in 
the paired domain rather than in the homeobox which may be variably included or even 
non-existent (88) Only three of the eight known Pax genes contain a homeodomain (89). 
The LIM homeodomain-containing proteins bear a cysteine-histidine-rich domain which 
may enable it to bind DNA. The POU family of genes was originally discovered as a 
group of transcription factors responsible for tissue specific gene expression. Examples 
include the Oct-2, LFB1 and GHF-1 proteins which are expressed in B lymphocytes, the 
liver, and the pituitary, respectively (90, 91,92, 93, 94). These expression patterns 
suggested that homeobox genes play a role in maintaining the differentiated state of adult 
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cells in addition those involved in embryogenesis. 
Homeobox genes in hematopoiesis 
In the last five years, several groups have identified homeobox gene expression in 
hematopoietic cells. Most of the initial studies concentrated on leukemia cell lines whose 
phenotypic pattern suggested specific lineage commitments. Newer data incorporates the 
use of normal hematopoietic cells selected by cell surface antigen characteristics. 
HOX genes in hematopoiesis 
The earliest studies reporting homeobox gene expression in hematopoiesis utilized 
Northern blot analysis against leukemia cell lines of varied phenotype (95, 96, 97). 
Although some of the preliminary conclusions have been modified, these experiments 
suggested that the homeobox gene transcription factors were active in hematopoietic cells 
and predicted that certain ones were lineage specific. 
Further studies attempted a more targeted analysis of HOX expression. Shen et al. 
screened four members of the HOX B locus in 18 leukemia cell lines representing 
erythroid, granulocyte-macrophage, macrophage, and B- and T-lymphoid lineages. It was 
concluded that HOX B4, B5, B6, and B7 are expressed predominantly in the erythroid cell 
lines. This study also noted that as two erythroid cell lines were induced to differentiate, 
the levels of HOX B4 transcription increased while the levels of one species of the HOX 
B7 transcript decreased (96). 
Since it appeared that the HOX genes were lineage specific and that groups of HOX 
genes within certain loci were restricted in expression pattern, larger studies examined the 
expression patterns of all class I homeobox genes in leukemia cell lines. Magli et al. 
looked at the expression of the 38 class I genes in four cell lines representing erythroid, 
myeloid and lymphoid lineages. They noted that: 1) the HOX D locus was not active in 
any of the cell lines, 2) the HOX B locus was restricted to the erythroid lines, 3) in the 
HOX A locus, four of the 5’ genes (HOX A9, A10, Al 1, A12) were not expressed in the 
erythroid lines but were expressed in the myeloid and lymphoid lines, and 4) in the HOX C 
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locus, four of the 5' genes (HOX CIO, Cl 1, Cl2, Cl3) were expressed in the erythroid 
lines but not expressed in the myeloid and lymphoid lines. HOX C5, C6, C8, and C9 
were expressed in all four lines. They concluded that not only is class I gene expression in 
hematopoietic cells lineage specific but that it may be coordinated by switching entire or 
parts of HOX loci on and off (98). In support of this study and utilizing 19 cell lines of 
varied lineage, Matthews et al. showed that with the exception of HOX B7, HOX B locus 
expression was restricted to erythroid cell lines (99). 
As the methods of reverse-transcriptase polymerase chain reaction (RT-PCR) 
became more widely practiced, several studies reported HOX expression patterns which 
conflicted with some of the earlier data utilizing Northern blotting (100, 101). These 
results are likely to be due to the higher sensitivity of RT-PCR versus Northern blot for 
detecting low levels of expression. Also, Deguchi et al. showed that HOX B7 levels were 
rapidly increased during activation of mature T-cells (97). Taken together, these data 
probably reflect the varying stages of homeobox expression in the specific "windows" of 
hematopoiesis reflected in the available leukemia cell lines and not in normal cells. Future 
data will need to identify homeobox expression in normal bone marrow cells selected for 
specific lineage characteristics by antigen-typing. 
Possible function of HOX genes in hematopoiesis 
Recent experiments have utilized antisense oligonucleotides to block homeobox 
expression by RNase-H degradation of the mRNA/oligo duplex in vitro. Shen and Detmer 
used an antisense HOX B6 expression vector to downregulate endogenous expression 
HEL and found that the erythroid features of the cell increased. Overexpression of the 
same gene in the K562 myeloerythroblastic cell line resulted in decreased erythroid 
characteristics such as alpha globin synthesis (102). Takeshita et al. identified the 
expression of several HOX C cluster genes in a mouse erythroleukemia cell line by RT- 
PCR. It was shown that HOX C6 transcription increased as the cells were induced to 
differentiate. Antisense oligonucleotide down-regulation of HOX C6 expression led to 
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decrease in proliferation of CFU-E-derived colonies but left the proliferation of BFU-E- 
derived and myeloid colonies unaffected. Terminal maturation indices such as 
hemoglobinization were not affected (84) These studies support the earlier Northern blot 
expression data and demonstrate that certain homeobox genes have precise roles in specific 
aspects of hematopoiesis, namely that both induced expression and down-regulation are 
vital to hematopoietic differentiation. 
Divergent homeobox genes in hematopoietic cells 
As discussed above, the divergent homeobox genes retain the highly conserved 
region of the homeobox, but may be grouped into families which share particular 
homologous sequences within the homeodomain. Table 2 contains a summary of the 
divergent homeobox genes expressed in hematopoietic cells. 
The first evidence that divergent homeobox genes were involved in hematopoiesis 
was the isolation of the S8 homeobox from a mouse spleen library by Kongsuwan et al. 
However, it was noted that S8 most likely originated from supporting stromal cells since it 
was expressed in a fibroblastic cell line and could not be detected in any hematopoietic cell 
lines by Northern analysis (95). 
Currently, several divergent homeobox genes are known to be expressed in 
hematopoietic cells and cell lines. HB9 and HB24 were isolated from a B-lymphocyte 
cDNA library (103). The HB24 gene was found to be homologous to the murine Hlx gene 
and is now known as HLX (104). HLX and HB9 are located on chromosome 1 and are 
therefore separate from the HOX loci. Both HLX and HB9 were found to be strongly 
expressed in the CD34+ fraction of bone marrow cells and silent in the CD34- fraction. 
Inhibition of expression of HLX by antisense oligonucleotide-directed down-regulation 
interfered with the proliferative potential of CD34+ cells treated with IL-3 and GM-CSF. 
In addition, the levels of other early transcription factors such as c-fos, c-myc, and c-myb 
were decreased (103). Takeshita et al. reported expression in myeloid cells but found that 
within the CD34+ fraction of hematopoietic cells, HLX was expressed in the 
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CD34+HLA+DR+ but not in the CD34+HLA-DR- fractions. Since the CD34+HLA-DR- 
cells contain pluripotent stem cells and can replete ablated bone marrow, HLX seems to be 
activated at an early point during hematopoiesis. Additionally, antisense experiments 
showed that down-regulation of HLX inhibited myeloid but did not influence erythroid 
progenitor colony formation (105). These data on HLX expression suggest a role for HLX 
in early myeloid commitment and that its expression is linked to the expression of other 
known transcription factors. 
Xu et al. isolated LH-2, a member of the LIM family of homeobox genes, while 
screening for markers of early B-lymphocyte differentiation. It was expressed in 
hematopoietic cell lines in a lineage-specific manner. Specifically, expression was identified 
in several pre-B-cell-stage cell lines and only at much lower levels in those cell lines 
reflecting more mature B-lymphocyte development. In T-lymphocytes, its expression did 
not appear to be restricted to any particular stage of differentiation (106). 
Several groups have used RT-PCR with divergent oligonucleotide primers to probe 
for new homeodomain-containing genes in hematopoietic cells. Using this protocol, the 
human equivalents of the murine Msx-2 and Dlx-1 genes were isolated from two myeloid 
leukemia cell line cDNAs. These genes are now known as MSX-2 and DLX-1 and had not 
been previously described in human hematopoietic cell lines (105). The human equivalent 
of the murine Cdx gene was isolated from the Jurkat human T-cell leukemia line (107). 
Cdx has subsequently been shown to be expressed in the murine myeloid leukemia cell 
line, B6-SUT (unpublished data). PRH (also known as HEX) was isolated from chicken 
myeloid leukemia cells, the human promyelocytic HL60 cell line, normal human bone 
marrow, and peripheral blood. Northern blot expression analysis determined PRH to be 
expressed in multilineage progenitor cell lines and specifically in myeloid and some B- 
lymphocyte cell lines. Among non-hematopoietic tissues, it was found only in the liver 
(108, 109); (110). GBX1 has recently been cloned from a human genomic DNA library 
and has been mapped to chromosome 7 near the region occupied by the EN-2 Homeobox 
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gene. Northern blotting confirmed expression within the hematopoietic compartment and 
specifically in the myelo/erythroblastic K562 and Daudi cell lines (111). The Oct 11 gene, 
a member of the POU family, was found to be expressed in a mouse myeloma cell line 
(112). 
The ultimate strategy for examining homeobox gene expression in hematopoiesis 
would involve lineage-specific cells from normal bone marrow during stem cell 
commitment. These experiments would validate the earlier studies and eliminate the 
chance that normal expression patterns are altered in transformed cells or during the 
establishment of the leukemia cell lines. Preliminary experiments have noted the 
expression of certain HOX B genes in normal bone marrow by Northern blot analysis (96, 
99, 97). 
Homeobox genes and hematologic malignancies 
A logical extension of the discussion of transcription factors in general and of 
homeobox genes in particular would be their potential role in hematologic malignancies. 
Since the activity of these genes has clearly been implicated in the differentiation of 
hematopoietic tissues, three mechanisms for dysregulating expression could account for 
leukemogenesis. A normally expressed homeobox gene or group of genes could be over¬ 
expressed or under-expressed leading to a shift in the delicate balance of the factors 
controlling cell growth characteristics and subsequent cell transformation. Also, a 
homeobox gene could become expressed ectopically either as a direct result of a specific 
genetic insult or by induction along an entire cascade of dysregulated transcription factors. 
Several examples of these phenomena have already been noted in the literature. The 
murine myelomonocytic leukemia cell line, WEHI-3B, was shown to have a retroviral 
insertion in the 5' non-coding region of Hox b8 leading to abnormal expression of the 
gene. This cell line also has a retroviral insertion upstream of the IL-3 gene. 
Overexpression of IL-3 alone did not induce leukemia, but co-infection of retroviruses 
carrying IL-3 or IL-3 plus Hox b8 into murine bone marrow resulted in myelomonocytic 
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leukemia only with the combination of IL-3 and Hox b8 (113, 114, 115). When Hox b8 
was overexpressed in a myeloid cell line, terminal differentiation was inhibited (116). 
These results suggest that Hox b8 may function as an oncogene and prevents terminal 
differentiation of myeloid cells in response to growth factors. 
Two specific chromosomal translocations in human leukemias led to the discovery 
of the divergent homeoboxes, HOX 11 and PBX1. 5-7% of T-cell ALL have a 
t( 10; 14)(q24,ql 1) translocation which fuses a portion of the T-cell receptor (TCR) delta 
with the coding region of HOX 11 leading to its overexpression in these cells. A rarer 
translocation, t(7;10)(q35,q24), places HOX11 immediately downstream to the TCR-B 
gene. Normal T-cells express HOX 11 at much lower levels (117, 118, 119). Subsequent 
overexpression of HOX11 in transfected NIH3T3 cells resulted in cell transformation 
(120). 
25% of B-cell ALL contain the translocation t( 1; 19)(q23,p 13.3) which fuses the a 
portion of the E2A gene with a divergent homeobox gene now called PBX1. E2A protein 
normally binds to the enhancer of the immunoglobulin kappa light chain gene in B-cells. 
PBX1 is normally expressed in several adult tissues, but not in normal developing B-cells 
(121, 122, 123, 124). This fusion protein contains both a homeodomain and an activator 
for immunoglobulin transcription and may act to incorrectly target E2A action on regions 
which are normally responsive only to PBX1. As with other homeobox genes, the E2A- 
PBX1 fusion gene results in several alternatively spliced transcripts. The proteins encoded 
by two of these transcripts from the fusion gene have been shown to result in tumors in 
nude mice injected with transfected NIH3T3 cells (125). 
In addition, HLX has been implicated in leukemogenesis (103, 126). 
Overexpression of this gene in a human T-cell line (Jurkat) resulted in increased cell 
proliferation and also led to the formation of tumors when injected into nude mice (127, 
128). 
Approach to the study of divergent homeobox gene expression in hematopoiesis 
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These results suggest that, as a group of transcription factors with DNA-binding 
ability, the homeobox genes may control hematopoiesis and serve as protooncogenes and, 
when deregulated, are able to control certain events crucial to leukemogenesis. With this in 
mind, I studied homeobox gene expression in a new cell line, TS9;22, which was 
established from a CML patient in megakaryocytic blast crisis. The aim of the study was to 
identify homeobox genes which may be involved in leukemogenesis and/or 
megakaryocytopoiesis. 
As an established, stable cell line TS9;22 contains both myelo/monocytoid and 
megakaryocytic characteristics. The immunophenotypic composition (by CD and HLA 
antigens) of both the patient and TS9;22 are presented in Table 3. Although TS9;22 is a 
stable cell line, it contains a heterogeneous population of cells which show characteristics 
of several individual cell types. Also, it is important to note that the immunophenotype of 
the cells assayed changed over a period of two years and after establishment of the cell line 
(129). 
Utilizing RT-PCR with divergent primers designed to identify all classes of known 
divergent homeoboxes, I isolated a new homeobox gene in the TS9;22 cell line and studied 
its expression in various leukemia cell lines and non-hematopoietic cells. 
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METHODS AND MATERIALS 
Cell lines 
The six cell lines used and their defining characteristics are summarized in Table 4. 
Cell culture and RNA extraction 
TS9;22, ES, HL60, MEL, KG1 and MegOl cell lines were grown as described 
(130, 131); (132, 133); (134). The TS9;22 cell line is cultured in RPM1 1640 +15% FCS 
(K. Ohyashiki (unpublished data)). Large-scale preparations of total RNA were made using 
the acid guanidine procedure (135). Poly-A+ RNA was isolated by hybridization of 500p,g 
total RNA (estimated by OD260) with biotinylated oligo-dT followed by selection with 
MagneSphere streptavidin paramagnetic particles (PolyATtract mRNA Isolation Systems, 
Promega) according to the manufacturer's protocol . The poly-A+-mRNA was then 
extensively treated with RNase-free DNase (Gibco-BRL) prior to cDNA synthesis and 
subsequent RT-PCR screening for divergent homeobox expression. These DNased poly- 
A+-mRNA samples were then tested with the PCR primer pair, 2551-2552 (84), to certify 
that all contaminating genomic DNA was removed. The PCR conditions were 94°C for 1 
min., 47°C for 1.5 min., and 72°C for 2 min. for 35 cycles, using 1 pig of each primer and 
1 ptl of the DNased poly-A+-mRNA. 
First-strand cDNA synthesis 
First-strand cDNA was synthesized from the DNase-treated polyA+ mRNA with 
M-MLV reverse transcriptase according to the directions in the Superscript Preamplification 
System (Gibco-BRL). cDNAs were prepared with both random hexamer and oligo-dT 
primers. The random hexamer derived cDNAs were then tested with the PCR primer pair, 
2551 and 2552 (84) (see Table 5), to determine if the cDNA was intact and if it contained 
HOX homeodomains. The PCR conditions were 94°C for 1 min., 47°C for 1.5 min., and 
72°C for 2 min. for 35 cycles, using 1 pig of each primer and lpil of the cDNA. 
RT-PCR 
The TS9;22- and ES-derived cDNAs were initially selected for study. RT-PCR 
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was performed exactly as previously described (84, 136) except that the 5' primers shown 
in Table 5 were used in order to detect the amino acid sequences characteristic of 19 types 
of divergent homeobox genes in addition to the class I HOX genes. The PCR conditions 
were 94°C for 1 min., 47°C for 1.5 min., and 72°C for 2 min. for 35 cycles, using lpg of 
each primer and lpl of the cDNA synthesized with the random hexamer primer. The PCR 
products were viewed on a 3% agarose gel . 
Subcloning of PCR fragments 
The TS9;22 PCR products were selected for study. The reactions which produced 
a visible ~150bp band were reamplified under the same conditions. These fragments were 
then ligated into the TA Cloning vector (Invitrogen Coip.) exactly as described by the 
manufacturer's protocol. 
Competent cells were transformed with the ligated DNA, and positive clones were 
picked by B-galactosidase blue-white selection. Nine homeobox clones were characterized 
by dideoxy sequencing using Sequenase (US Biochemicals). Of the three different 
homeoboxes identified, a single clone containing a homeobox derived from the TS9;22 
poly A+ mRNA (PAX-TS) was selected for further analysis. 
RNA expression analysis 
The RNase protection assay for PAX-TS was performed as follows: ljig of the 
plasmid containing the PAX-TS homeobox DNA was linearized with Xhol (see Figure 11 
for orientation of insert in TA Cloning vector). Antisense mRNA was radiolabeled by 
runoff transcription with SP6 RNA polymerase (Promega) in the presence of lOOpCi of 
alpha- P CTP at a specific activity of 600Ci/mmol. The reaction mixture was treated with 
RNase-free DNase (Gibco-BRL), extracted with phenol-chloroform, and gel purified from 
a denaturing 5% polyacrylamide gel to eliminate minor products of transcription. 
For the RNase-protection assay, 500,000cpm of the radiolabeled antisense probe 
were used per reaction. 15pg of each of TS9;22, HL60, MegO 1, KG 1, and MEL total 
RNA suspension were co-precipitated along with the antisense probe. As a positive 
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control, a cold, sense mRNA probe from the same plasmid linearized with Hindlll was 
prepared by runoff transcription with T7 RNA polymerase. 1 pi of a 1:500 dilution of the 
cold probe was used per reaction. Sterile water served as a negative control assay. The 
pellet was washed with 70% ETOH and resuspended in 30pl 5X PIPES (200mM PIPES 
(pH6.7), 2M NaCl, ImM EDTA) diluted to IX with formamide. The RNA was denatured 
at 85°C for 5 min. and then allowed to hybridize at 45°C overnight. After hybridization, 
the mixture was cooled to room temperature and digested with 300pl RNase digestion mix 
(lOmM Tris (pH7.4), 5mM EDTA, 300mM NaCl, 40pg/ml RNaseA, lpg/ml RNaseTl) at 
30°C for 60 min. to remove the non-hybridized, single-stranded RNA . Following 
removal of the RNases and protein with proteinase-K in 1% SDS, the resulting reaction 
mixture was extracted with phenol-chloroform, ETOH precipitated, and loaded onto a 
denaturing 5% polyacrylamide gel (1200V, 40mA, 2hrs). The gel was autoradiographed 
with an intensifying screen. 
Oligonucleotide preparation 
Oligonucleotides specific for the TS9;22 homeobox under consideration (PAX-TS) 
were ordered (Figure 13). These oligonucleotides correspond to the base sequence internal 
to the divergent PCR primers 3766 and 2552. The sequences of the oligonucleotides were: 
TGCAGCTAGAGGAGCTGGAG, TS-1; GCTAGAGGAGCTGGAG, TS-2; 
GATGTGTATGTCAGAGAACA, TS-3; TGAGGACAGAGCTCACTGAG, TS-4; 
corresponding to the sense strand and CTGGGACCGGAGTCACTCG, TS-RA; 
CAGTGAGCTCTGTCCTCAG, TS-RB; corresponding to the antisense strand. 
Determination of the specificity of primers 
RT-PCR with primers TS-1 and TS-RA was performed on total RNA, DNased 
total RNA, and first-strand cDNA derived from the TS9;22, MegOl, ES, HL60, KG1, and 
MEL cell lines described above, followed by Southern blotting, l^-microglobulin-specific 
primers and DLX-1-specific primers were used as positive cDNA controls (105). 
The concentration of total RNA in each sample was estimated by OD250 anc* 
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adjusted so that the amounts were approximately equal prior to DNase treatment and cDNA 
synthesis. The PCR conditions were 94°C for 1 min., 55°C for 1.5 min., and 72°C for 2 
min. for 30 cycles, using lpg of each primer and lpl of the cDNA synthesized with the 
oligo-dT primer. The PCR products were viewed on a 3% agarose gel. These samples 
were then Southern blotted and hybridized with a radiolabeled TS-3 probe. For Southern 
blotting hybridization, lOng of the oligonucleotide were labeled with 50pCi gamma-^"P 
ATP in the presence of polynucleotide kinase (NE Biolabs). After prehybridization of the 
filter (50% formamide, 1M NaCl, 1% SDS, 10% dextran sulfate) in sealable plastic bags at 
50°C for 3 hours, the radiolabeled oligonucleotide was suspended in salmon sperm DNA 
(150jig/ml) and added to the prehybridization mix. Hybridization was carried out at 43°C 
overnight. The filter was rinsed for 1 min. in 2X SSC, and washed in TMAC (3M 
tetramethy 1 ammoniurn chloride, 2mM EDTA, 50mM Tris-HCl (pH 8.0)) at room 
temperature for 30 min at room temperature. It was then washed in TMAC, 0.2% SDS at 
53°C for 10 minutes, and finally re-rinsed in TMAC for 10 min. at room temperature 
(137). 
The ~ 150bp band formed by PCR of TS9;22 cDNA with the TS-1 and TS-RA 
primers was reamplified and cloned into the TA Cloning vector as described above. DNA 
was isolated from small scale cultures and sequenced by the dideoxy method to verify the 
specificity of the TS-3 and TS-RA primers for PAX-TS. 
PAX-TS expression in bone marrow and in CML 
RT-PCR and Southern blotting was additionally performed on 200ng of cDNA 
from two adult human bone marrow samples to assess expression in hematopoietic cells. 
Total RNA extracts from the patient with CML whose bone marrow in blast crisis was used 
to establish the TS9;22 cell line described above were also obtained. Both chronic phase 
and subsequent blast crisis total RNA were available for analysis. In order to assess 
expression of PAX-TS in this patient, 3.2|ig of total RNA from the blast crisis (BC) and 
chronic phase (CP) were treated with RNase-free DNase and then used as a template for 
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first-strand cDNA synthesis with oligo-dT as described above for RT-PCR. The PCR 
conditions were 94°C for 1 min., 55°C for 1 min., and 72°C for 2 min. for 30 cycles, 
using 1 gig of each primer, lpl of DNased total RNA, and l|al of the cDNA . The PCR 
products of the DNased total RNA and cDNA samples were viewed on a 3% agarose gel, 
Southern blotted and probed with radiolabeled TS-3 oligonucleotide as described above. 
RT-PCR expression analysis of other tissues and organs 
RT-PCR analysis was performed on mouse genomic DNA to identify the murine 
equivalent of PAX-TS, and on first-strand cDNA prepared from DNased-total RNA from 
an eleven day mouse embryo to assess expression in developing tissues. A comparison of 
the TS-1, TS-2, TS-RA, and TS-RB primer pairs for PCR recognition of PAX-TS in the 
human and mouse was made. Each of the four combinations of primers was used: TS-1 
and TS-RA, TS-1 and TS-RB, TS-2 and TS-RA, and TS-2 and TS-RB. The PCR 
conditions were 94°C for 1 min., 62°C for 1.5 min., and 72°C for 2 min. for 30 cycles, 
using lpg of each primer and lpg and 1.3pg of the mouse and human genomic DNAs, 
respectively. The PCR products were viewed on a 3% agarose gel. Southern blotted and 
hybridized with radiolabeled TS-3 oligonucleotide as described above. 
Organ lysates (lung, kidney, liver, spleen, colon, stomach, small bowel, and 
skeletal muscle) from an adult rat were obtained. Total RNA was extracted from 1ml of 
each lysate by the acid guanidine procedure as described above (135). The concentration of 
total RNA in each sample was estimated by OD250 and adjusted so that the amounts were 
approximately equal. Total RNA, DNased total RNA, and first-strand cDNA synthesized 
with oligo-dT primer were prepared. The PCR conditions were 94°C for 1 min., 55°C for 
1 min., and 72°C for 2 min. for 30 cycles, using lpg of each primer (TS-1 and TS-RA) 
and 1 Jill of the cDNA . The PCR products from the DNased total RNA and cDNA samples 
were then run on a 3% agarose gel. Southern blotted, and hybridized with the radiolabeled 
TS-3 probe as described above. 
The ~150bp fragments from the PCR experiments on the mouse genomic DNA and 
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on the rat kidney cDNA were cloned into the TA Cloning vector as described above. DNA 
was isolated from small scale cultures and then sequenced by the dideoxy method to 
compare the human, rat, and mouse homologues of the PAX-TS homeobox. 
PAX-TS screening in genomic and cDNA libraries 
Murine cDNA (Clonetech) and human genomic DNA libraries were screened 
unsuccessfully by the standard method using both the radiolabeled TS-3 oligonucleotide 
and the cloned PAX-TS cDNA PCR fragment as probes. Possible explanations for this 
difficulty will be addressed below. 
Isolation of the PAX-TS genomic clone 
The four primers TS-1, TS-2, TS-RA, and TS-RB were submitted to Genome 
Systems, Inc. for genomic library screening by PCR (138, 139, 140). A ~70kb genomic 
clone packaged in bacteriophage PI was isolated. The control PI phagemid and PI 
phagemid containing the genomic insert were isolated from 250ml cultures in LB + 
kanamycin 2 5 jig/m 1 induced with IPTG. They were digested with BamHI, EcoRI, and 
Hindlll, run on a 0.8% gel, Southern blotted and hybridized with radiolabeled TS-3 
oligonucleotide as described above. 
Subcloning of DNA fragments from PI genomic clone 
In order to subclone the lOkb EcoRI fragment which hybridized to the TS-3 probe, 
lOpg of the PI clone was digested with EcoRI overnight in the presence of excess RNase. 
The digested DNA was phenol-extracted, ETOH-precipitated and ligated overnight into 
predigested Lambda Zap II/EcoRI/CIAP phage arms according to the manufacturers 
protocol (Stratagene). In this manner, we created a phage library containing ~20 different 
EcoRI inserts from the lOOkb genomic DNA. The ligation was packaged into phage using 
the Gigapack II packaging extract exactly as described by the manufacturer. The phage 
was stored in 5Q0|il SM buffer in the presence of 20ql chloroform. 
The phage library was then screened by PCR using the TS-1 and TS-RA primers 
for detection of positive clones. The ligation efficiency was determined by 6-galactosidase 
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blue-white selection (-70% clear plaques) and the phage titer was measured by serial 
dilutions. Approximately 500 phage particles were plated onto ten 100mm diam. 
LB+10mM MgSC>4 plates (for a total of 5000 phage particles) in the presence of 200)il 
XLl-Blue MRF' cells (OD^qq=0.5) (Stratagene) and 3ml top agar. The phage were eluted 
by adding 3ml SM buffer directly onto the plates and incubating for 2 hours at room 
temperature on a shaker. The eluates were transferred to eppendorf tubes, spun in the 
microfuge for 2 minutes to pellet any bacteria and agar, and then transferred to fresh 
eppendorf tubes for PCR analysis. The PCR conditions were 94°C for 1 min., 60°C for 
1.5 min., and 72°C for 2 min. for 30 cycles, using 0.5jig of each primer and 1 pi of the 
phage eluate. Eluates which produced "positive" PCR bands were saved. 
In the next screening step, approximately 30 phage particles from a "positive" eluate 
were plated onto twelve 20mm diam. LB+10mM MgSOq plates (for a total of 500 phage 
particles), eluted, and analyzed by PCR as described above. The eluate which produced a 
"positive" PCR band was retitered and plated onto a single 100mm diam. LB+10mM 
MgSC^ plate for a total of -50 phage plaques using the B-galactosidase blue-white selection 
to screen for phage containing inserts. Individual plaques were selected, eluted in 200pl 
SM buffer as described above, and analyzed by PCR. The eluate which resulted a 
"positive" PCR band represents a single clone containing the lOkb PAX-TS genomic 
insert. 
The lOkb PAX-TS genomic insert was rescued by in vivo excision using the 
ExAssist /SOLR system (Stratagene) which places the fragment into the EcoRI site of the 
Bluescript plasmid. 16 individual colonies were picked. The plasmid DNA from these 
colonies was then digested with EcoRI to isolate the PAX-TS fragment. 
Isolation of the PAX-TS cDNA clone 
The murine cDNA library (Clonetech, Inc.) was screened similarly to the genomic 
library. The cDNA library itself was screened using the PCR assay described above with 
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primers TS-1 and TS-RA . This initial screening confirmed that this cDNA library 
contained the cDNA clone of interest. Screening of this library by standard filter 
hybridization methods produced no clones. Thus, 1x10^ phage clones were plated onto 20 
plates (150 mm diam., 50,000 plaques per plate), and the bacteriophage eluted from the 
agar plate into 7 ml of SM phage buffer, lpl of the phage eluate was used in a PCR 
reaction using the primers TS-1 and TS-RA in order to localize the plate which contained 
the desired cDNA clone. 50,000 plaques from this fraction were then re-screened by the 
PCR assay. By successive screening of smaller and smaller fractions, a positive clone was 
isolated. 
After isolation of a single clone by PCR, a high titer stock of this phage clone was 
prepared as a liquid lysate and passed over a Qiagen column as per manufacturer's 
directions to prepare phage DNA. The DNA was digested with EcoRI to release the PAX- 
TS cDNA fragment, isolated from a 1% agarose gel by electroelution and passed over a 
Elutip-D column (Schleicher and Schuell) exactly as described by the manufacturer. The 
purified EcoRI fragment was ligated into an EcoRI-linearized Bluescript KS" vector in the 




Identification of homeobox gene expression in cell lines 
Figure 6 shows the 3% agarose gel of the initial PCR experiment in which the 
cDNAs derived from the ES, TS9;22, KG1 and MEL cell lines and DNased poly-A+- 
mRNAs were tested with the 2551 5'-class I homeobox primer. Compared to the Ikb 
ladder DNA size marker, there is a ~ 180bp band in the ES, TS9;22, KG, and MEL lanes 
using the l^-microglobulin primers, suggesting that the cDNA preparations were intact. 
There are also ~ 150bp bands in the ES, TS9;22, and KG1 treated with the HOX primers 
indicating that class I homeobox genes are expressed in these cell lines. The DNased poly- 
A+-mRNAs treated with the same primers failed to produce similar PCR products. 
Therefore, the DNase treatment of the mRNA successfully eliminated genomic DNA 
contamination from the reverse-transcriptase reaction substrates. 
Having shown that the first-strand cDNAs described above were intact, the TS9;22 
cell line was selected for RT-PCR analysis with the 19 divergent homeobox primers (Table 
5). The 3% agarose gels containing the PCR screening are shown in Figure 7. A summary 
this data is contained in Table 6. "+" results were recorded for a 150bp band with the class 
I (2551) primer and for a 160 bp band with the divergent primers. The divergent primers 
recognize a specific region of the homeobox which is upstream from the 2551 primer site 
and therefore, they produce a slightly larger PCR band on the 3% agarose gel. results 
include those primers which failed to produce a 160bp band or which produced large or 
multiple bands. 
Homeobox sequences 
The primers which yielded "+" PCR products from the TS9;22 cDNA included 
classI-HOX, Hox7.1/msh, and the xhox3/eve. These PCR products were cloned and 
sequenced and are shown in Figures 8 and 9. In Figure 10, the amino acid sequences of 
the three cloned homeoboxes are compared to the Antp. homeobox. The primer regions of 
each clone are in lower case letters since the actual gene may be degenerate within the 
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region of the primers and would not be represented in this PCR amplified product. The 
classI-HOX (2551) and msh primers identified the previously known genes, HOX B9 and 
MSX-2, respectively. Note that the classI-HOX-derived homeobox fragment from HOX 
B9 is shorter than the others since primer 2551 is designed to recognize the evolutionarily 
conserved sequence 'ELEKEF' of the class I genes which is 3' to the regions recognized 
by the Hox7.1/msh (3066) and xhox3/eve (3766) primers (84, 141, 142, 143, 144). 
Primer 2551 would not have recognized the msh- or xhox3/eve-derived homeobox 
fragments shown. 
Clones derived from the PCR reaction with the xhox3/eve primer appeared to be a 
previously undescribed gene. Using the sequence of these clones, a FASTA search of 
EMBL + Genbank databases showed that it represented a new gene in humans that is 
almost identical to a very recently described gene, Cart-1, which was isolated from a rat 
chondrosarcoma cell line (145). The two genes demonstrated 88% identity in a 138bp 
overlap and 100% identity in a 35 amino acid overlap (Figure 9). This gene also bears 
significant homology to the paired-type homeobox genes, such as Pax-3 which has 72% 
identity in a 113bp overlap and 67% identity in a 36 amino acid overlap (Figure 9). Based 
on this initial sequence information, and since the sequences 5' or 3' to the homeobox are 
currently under investigation, this new gene was preliminarily named "PAX-TS." 
Expression analysis 
In order to prove PAX-TS expression in the TS9;22 cell line, the RNase protection 
assay was performed (Figures 11,12). In Fane 1, the gel-purified, 290bp, radiolabeled 
run-off transcript is shown. It comprises 116bp of the TA cloning vector plus the 174bp 
PCR insert which contains 66bp of the two primers and 11 Ibp of actual coding sequence. 
The positive control. Fane 2, shows the RNase protection product of the radiolabeled probe 
and the cold, 296bp, opposite strand transcript. The overlap between the two transcripts is 
260bp, but the band in Fane 2 is only 215bp. This apparent discrepancy is most likely due 
to the fact that single stranded RNA products move faster than the denatured double 
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stranded DNA fragments of the pBR322/MspI marker on the polyacrylamide gel. The 
negative control. Lane 3, has no RNase protection product since sterile water was used 
instead of rriRNA template and the transcript was completely digested. Lanes 4, 5, 6 7, 
and 8 show the RNase protection products of the radiolabeled transcript against TS9;22, 
HL60, MegOl, KG1, and MEL total RNA. There are two bands, 123bp and 130bp in the 
TS9;22 lane. It is important to emphasize that the PAX-TS clone contains sequences 
which are not likely to be represented in the actual gene. These sequences correspond to 
the two degenerate primers at the ends of the clone (especially since one primer (3766) was 
designed to detect the Evx gene family). Thus, the actual bands are smaller than the 174bp 
insert. This fact may also explain why two degradation products appear on the gel, 
perhaps representing some secondary structure formation which interferes with digestion in 
a fraction of the PAX-TS-antisense probe population or a mismatch near the end of the 
insert. In any case, these results suggest that PAX-TS is expressed in the TS9;22 cell line 
at readily detectable levels, and not in any of the other cell lines studied. 
Having proven PAX-TS expression by the RNase-protection assay, RT-PCR was 
used to facilitate further expression studies. Figure 14 shows the RT-PCR results of 
screening the TS9;22 and MegOl total RNA, DNased total RNA, and first-strand cDNA 
with the PAX-TS-specific primers, TS-1 and TS-RA. Each sample is presented in a group 
of three after PCR with primers TS-1 and TS-RA, and with primers specific for the DLX 
and 82-microglobulin (82) genes. A human genomic DNA template was also used for 
comparison. The larger, minor bands in the PAX, DLX and 80 lanes are probably artifacts 
due to the high concentration of DNA in the reaction mix which leads to some non-specific 
binding. In lanes 5-13, the total RNA, DNased total RNA, and cDNA from TS9;22 were 
used as templates. In lanes 5-7, the PCR products show the same banding pattern as with 
the human genomic DNA, reflecting the genomic DNA contamination of the total RNA. 
After DNase treatment in lanes 8-10, these bands do not reappear. After reverse 
transcription in lanes 11-13, the 104bp PAX-TS product reappears and a shorter, single 
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PCR band appears in the DLX and B2 lanes, proving that cDNA is intact. The results 
generated in MegOl (Lanes 16-24), as well as in the HL60, KG1, MEL, and ES cell lines, 
were similar, except that the 104bp PAX-TS PCR product was not produced with these 
cDNA templates. 
Southern blot data from the RT-PCR experiments are presented in Figures 15. 
Only the human-derived cell lines (TS, MegOl, HL60 and KG1) were tested. The B2 
probe recognized its gene product in all four cell lines, but the radiolabeled TS-3 probe only 
hybridized to the PCR product in the TS9;22 and human genomic DNA lanes. The TS-3 
probe did not produce any signal in the DNased total RNA PCR lanes (data not shown). 
Dideoxy sequencing of the TS-l/TS-RA PCR product ligated into the TA Cloning vector 
demonstrated that it contains the identical sequence as was cloned using the xhox3/eve 
degenerate primer (data not shown). 
In summary, the results of the above RT-PCR, Southern blot and sequencing data 
suggest that TS-1 and TS-RA are specific for PAX-TS and may be used to screen for its 
expression by RT-PCR, and that PAX-TS is expressed preferentially in TS9;22 which is in 
concurrence with the RNase protection data. Since the Southern blot data agrees with the 
RNase-protection data, RT-PCR is a suitable instrument for evaluating PAX-TS 
expression. 
PAX-TS expression in the normal bone marrow 
The 3% agarose gel and Southern blot data from RT-PCR of two normal human 
bone marrow RNA samples is shown in Figure 16. On the gel, in lanes 2 and 3, the faint 
104bp bands corresponding to PAX-TS can be seen in the cDNA from the two bone 
marrow samples. Directly below, the B2-microglobulin controls for cDNA are shown. 
The corresponding Southern blot shows two faint bands corresponding to PAX-TS in both 
bone marrow samples, suggesting a very low level of PAX-TS expression in normal bone 
marrow. 
PAX-TS expression in a patient in CML blast crisis 

-34- 
Total RNA samples from the CML patient from which the TS9;22 cell line was 
derived were obtained. Both the chronic phase and blast crisis RNA samples were 
subjected to RT-PCR using the PAX-TS-specific primers. The 3% agarose gel and 
Southern blot data are presented in Figure 17. PAX-TS was only found to be expressed in 
the TS9;22 cDNA. 
PAX-TS in embrvogenesis 
Using the TS-1 and TS-RA oligonucleotide primers and RT-PCR, we are able to 
demonstrate PAX-TS expression in eleven-day mouse embryo RNA (Figure 18). This 
result suggests that PAX-TS does exist in the mouse and that it is expressed during 
embryogenesis. 
Murine homologue of PAX-TS 
We then attempted to identify the murine equivalent of PAX-TS by PCR. The 
agarose gel and subsequent Southern blot data for the PCR on human and mouse genomic 
DNA with the four combinations of primers (TS-1 and TS-RA, TS-1 and TS-RB, TS-2 
and TS-RA, TS-2 and TS-RB) are shown in Figure 19. As would be expected, the size of 
the PCR products decreases as the primer pairs move closer together. Note that in the 
mouse lanes (6-9), the PCR product vanishes as the TS-2 and TS-RB primers are used. 
On the Southern blot, only the human PAX-TS PCR products hybridize to TS-3 under the 
wash conditions used. These data suggest that while TS-1, TS-2, TS-RA, and TS-RB 
recognize and are specific for the human PAX-TS, the murine homologue has some degree 
of degeneracy in that it does not hybridize as well to TS-2, TS-RB, and TS-3 under the 
PCR and Southern blot conditions described. 
A comparison of the human and mouse PAX-TS homeobox sequence data is 
presented in Figure 20. In the region of the homeobox between the TS-1 and the TS-RA 
primers, there is 85.9% DNA homology but only a single amino acid difference. 
PAX-TS expression in rat organs 
The RT-PCR data on the rat organ lysates is shown in Figure 21. Of the organ systems 
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tested, PAX-TS expression was localized to the kidney (lane 2). The Southern blot made 
from a similar gel, with the DNased total RNA samples as controls to rule out genomic 
DNA contamination and with TS9;22 and MegOl cDNA as positive and negative 
expression controls, demonstrates a positive signal only in the positive control lane, 
suggesting that the oligonucleotide probe does not recognize the rat homologue in the 
region of the TS-3 primer under the conditions used. However, direct cloning and 
sequencing of this PCR product confirmed its identity as PAX-TS. 
A comparison of the human and rat PAX-TS homeodomain sequence data is 
presented in Figure 20. In the region of the homeobox between the TS-1 and TS-RA 
primers, there is 85.9% DNA homology but 100% amino acid conservation. 
Stringency of the TMAC wash conditions 
It is important to note that, in the region of the radiolabeled primer, 
GATGTGTATGTCAGAGAACA, there is only a single base change in both the rat and 
mouse which interferes with its ability to hybridize to TS-3 under the conditions we used 
for the Southern blot wash with TMAC. The fact that TMAC is highly sequence specific 
and can distinguish single base differences explains why the rat and mouse homologues of 
PAX-TS were not identified in the Southern blot data (137). 
PAX-TS genomic clone 
We were unsuccessful in obtaining a PAX-TS genomic clone by the standard 
method of filter hybridization. Thus, a PI phagemid clone carrying ~70kb of genomic 
DNA around PAX-TS was obtained from Genome Systems, Inc., who used the PAX-TS- 
specific primers to isolate this clone. The Hindlll, BamHI, and EcoRI digests of the 70kb 
genomic DNA insert in the PI plasmid are shown in Figure 22. The uncut, supercoiled 
plasmid is in lane 6. Southern blot hybridization with the PAX-TS-specific TS-3 probe 
demonstrates ~8kb Hindlll, ~5kb BamHI, and ~9kb EcoRI fragments in lanes 7-9 (Figure 
23). 
Several strategies were employed to subclone the PI clone. Random cloning with 
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colony hybridization and direct cloning using gel-purified DNA fragments did not yield any 
clones containing PAX-TS. Random subcloning into a phage vector created a "mini¬ 
library" which was successfully screened by PCR, using the PAX-TS-specific primers. 
Figure 24 shows the secondary PCR screening step in which the number of phage 
particles containing the PAX-TS genomic insert was reduced from 1 in 500 to 1 in 50. A 
similar screening step isolated a single phage particle containing PAX-TS from a plate of 50 
plaques. However the rescued Bluescript plasmid did not contain the correct insert. The 
insert in every clone was only 3kb and it was negative for PAX-TS by PCR analysis. 
Sequencing the ends of this insert from the T3 and T7 promoter binding sites in Bluescript 
did not yield any recognizable genes after a EMBL + Genbank databank search (data not 
shown). 
PAX-TS cDNA clone 
A phage clone containing PAX-TS sequences was isolated from a mouse day 11 
embryo library using a PCR screening technique as described in Methods. This clone 
contained a 1.2kb EcoRI fragment, as confirmed by the Southern blot (Figure ; this Figure 





As a family of transcription factors, the homeobox genes have been implicated in 
the regulation of cell differentiation in both embryogenesis and adult tissues. In addition, it 
has been shown that dysregulated homeobox gene expression may function in the 
development of both solid tumors and hematologic malignancies. Studies on the 
homeobox genes and other transcription factors indicate that the molecular events occurring 
during embryogenesis and carcinogenesis may share many common features. 
Hematopoiesis provides an excellent model for studying normal and abnormal cell 
differentiation. 
Since very little is known about hematopoiesis at the level of transcription, and 
since both class I and divergent homeobox genes are believed to contribute to this process, 
my aim was to identify new divergent homeobox genes in hematopoietic cells. My long¬ 
term goal was to show that these genes were essential to the normal development of 
hematopoietic cells or were important in leukemogenesis. 
The use of degenerate primers to identify novel divergent homeobox genes 
An RT-PCR strategy using degenerate oligonucleotide primers designed to detect 
new members of the known divergent homeobox gene families has been successful in 
identifying the expression of several genes in hematopoietic cells including MSX-2, DLX- 
1, CDX, and GBX (105, 107, 111). This strategy has proven to be simpler than former 
methods of cDNA library screening which required the use of radiolabeled probes to 
conserved sequences under low stringency wash conditions. 
I used this RT-PCR strategy to identify a new homeobox gene in a megakaryocytic 
leukemia cell line, TS9;22. In addition, the MSX-2 and HOX B9 homeoboxes were also 
cloned from this cell line. The new gene, named PAX-TS was cloned using a PCR primer 
designed to detect the evx family of divergent genes which contains the amino acid 
sequence "RRYRTAFT" at the 5' end of the homeobox. However, for the PCR screening 
of TS9;22, a low annealing temperature of 48°C was used in order to decrease the 
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specificity of the primer's binding. This strategy allowed for the detection of related, but 
slightly different sequences. The sequence of the PAX-TS homeobox is only 30% 
homologous to the mouse Evx-1 gene so it will be of interest to analyze the sequence of the 
entire PAX-TS gene from either a genomic or cDNA library to determine if the actual gene 
contains the evx-like 5' region, although this is unlikely. 
A. ANALYSIS OF THE PAX-TS GENE 
PAX-TS has a "paired-like" homeodomain 
DNA and amino acid sequence homology analysis suggest that PAX-TS is a 
member of the "paired-like" homeobox genes (Figure 9). The "paired-like" grouping 
includes the six of the eight members of the Pax family which, as discussed earlier in the 
Introduction (page 15), contains the highly conserved "paired" amino acid DNA-binding 
motif upstream of a complete or partial homeodomain. Pax-1 and Pax-5 do not contain a 
homeodomain (88). Additional members of the "paired-like" group include S8, ceh-10, 
otd, gsbBSH, and srnox-3 (isolated from Schistosoma mansoni) which retain between 50 
to 75% homology to the cloned PAX-TS homeobox (146, 147, 148, 149, 150). These 
genes do not contain paired domains and are considered distinct from the Pax family. 
Based on the existence of these three types of genes: paired domain without a 
homeodomain, paired domain with a homeodomain, and homeodomain without a paired 
domain, it has been suggested that the Pax family arose via chromosomal crossovers 
between ancestral paired and homeobox genes with subsequent divergence and duplication 
(88). Therefore, the Pax genes without homeodomains (Pax-1 and Pax-5) and the "paired- 
like" genes may represent more ancient evolutionary relatives of the current Pax genes. 
PAX-TS may fit into this classification. 
Very recently, during the course of my studies, Zhao et al. published the sequence 
of a homeobox gene, Cart-1, from a rat chondrosarcoma cDNA library. At the nucleotide 
level, this gene is identical to the rat homologue of the PAX-TS gene over a stretch of about 
100 base pairs (145) (Figure 25). I have isolated human genomic and cDNA PAX-TS 
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clones and restriction mapping and sequence data is pending at this time. It is currently not 
known whether Cart-1 and PAX-TS are the same gene, although the identity between the 
rat PAX-TS and Cart-1 homeoboxes suggests that they are. However, even within a single 
species, many homeobox genes are virtually identical at the amino acid or nucleotide level 
within the homeodomain but differ in the remainder of the gene. The peptide sequences of 
the paralogous HOX A5 and HOXB5 genes and the divergent Xenopus msx-1 and msx-2 
genes are identical within the homeobox (151). Until the sequence upstream of the PAX- 
TS homeobox is obtained, I cannot exclude the possibility that the gene varies from Cart-1, 
and defines a new gene which may contain a paired domain. 
The Cart-1 cDNA clone includes a putative 326 amino acid coding region with a 
460bp 5' untranslated region. Only a single (1.3kb) mRNA transcript for Cart-1 was 
detected, and in analyzing overlapping cDNAs, no evidence for alternatively-spliced 
transcripts was demonstrated. However, this does not exclude the possibility that an 
alternative transcript which includes a paired domain does exist in some cell types or in 
certain diseases. 
Interestingly, the sequence of Cart-1 in the region of the 5' PCR evx primer is 
"RRHRTTFT." A comparison of the sequences at the nucleotide level demonstrates only 
two mismatches out of twenty. This motif is similar enough to the evx primer so that it 
would be detected under the "low-stringency" PCR conditions used to screen TS9;22. It is 
also quite similar to the 5' amino acid region shared by several genes including Pax-3 and 
Pax-7 which contain "RRSRTTFT" and smox3 which contains "RRIRTTFT" (Figure 9). 
If PAX-TS does, in fact, contain the RRHRTTFT 5' motif, it would have to be classified 
as a closer relative to the "paired-like" smox3 than to the Pax genes. 
Human-rat-mouse comparisons 
Figure 20 shows the DNA and amino acid sequence comparisons of the human, 
mouse, and rat homologues of PAX-TS. Except for a single amino acid change in the 
mouse, the peptide sequences of PAX-TS in the three species are identical. The DNA 
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variability is located in the "wobble" positions of each codon such that the amino acid 
specified is the same. This data supports the notion that homeobox gene sequences are 
highly conserved between distinct evolutionary species. This identity will also be helpful 
for future studies since it will be easier to draw conclusions about the behavior of PAX-TS 
in humans from experiments involving expression in the mouse. 
Cloning of the PAX-TS human genomic clone 
It was not possible to isolate a genomic PAX-TS clone using the standard method 
of screening a genomic phage library with the PAX-TS cDNA insert (174bp). Two 
explanations for the failure of this method are a potentially low specific-activity of the 
labeled, linearized plasmid probe and the small length of the probe itself. Under the wash 
conditions used, this probe may not have been sufficient to provide a strong enough signal. 
Thus, I obtained a PI phage clone carrying a 70kb insert which contained the PAX-TS 
gene. Direct subcloning into the Bluescript plasmid was attempted, using Geneclean II to 
gel purify the lOkb EcoRI PI-fragment in Figure 23. Unfortunately, owing to the large size 
of the PI phagemid, it was difficult to isolate enough insert from the EcoRI digest to 
facilitate a ligation. In addition, the large size of the insert (between 5 and lOkb) may have 
reduced the efficiency of the ligation reaction into the Bluescript vector. 
As a result, I resorted to constructing a phage "mini-library" from the EcoRI digest 
of the PI clone, and utilized a technique of screening successive phage titers by PCR with 
the PAX-TS-specific primers, TS-1 and TS-RA, as described in Methods. The screening 
method was essentially similar to the method recently described in (152). Unfortunately, 
even though this method appeared to successfully isolate a single phage containing the 
PAX-TS lOkb insert, none of the rescued Bluescript plasmids contained the proper insert. 
It appears that the PAX-TS insert is stable in phage but is rearranged during transfer to 
Bluescript during the ExAssist/SOLR rescue resulting in loss of the PAX-TS gene. It is 
possible that some repetitive sequence in the chromosomal DNA flanks the PAX-TS 
homeobox. Given the large size of the PAX-TS genomic insert, the likelihood of a 
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crossover event would be increased. Alternatively, given the low copy number of PI 
plasmids compared to the high copy number of Bluescript, the rescued Bluescript clones 
may be unstable (138, 139) . 
Since the PAX-TS clone appears to be stable in the lambda phage, I now plan to 
amplify the single PAX-TS-containing phage in culture, isolate the phage DNA, and digest 
the lOkb insert into smaller fragments which will then be subcloned into plasmids and 
characterized. This strategy may eliminate the possibility of DNA rearrangement. 
Cloning of the PAX-TS cDNA clone 
A 1,2kb EcoRI fragment was isolated after screening the mouse cDNA library by 
PCR. Southern blot data suggests that this fragment contains the PAX-TS sequence. 
Restriction mapping and sequence data are pending at this time. This data will confirm 
whether PAX-TS is the same gene as Cart-1 or represents a new gene whose homeobox is 
homologous to that of Cart-1. 
B. EXPRESSION STUDIES 
Expression pattern in leukemia cells and in normal bone marrow cells 
The RNase-protection data demonstrates that PAX-TS is expressed at measurable 
levels in TS9;22 but not in any of the other cell lines assayed, including those with 
predominantly erythroid (MEL), myeloid (HL60, KG-1), and megakaryoblastic (MegOl) 
characteristics. From this limited selection of cell lines it is not possible to hypothesize as 
to whether PAX-TS displays lineage-restricted expression. 
If PAX-TS is identical to Cart-1, it is possible to explain the sizes of the RNase- 
protection products. It was postulated that, since the PAX-TS homeobox clone was 
generated with PCR using degenerate primers, the actual gene may differ in the region of 
the two primers. Comparison of the PAX-TS and Cart-1 sequences demonstrates that 
they do differ at both primer sites. The evx primer sequence is "RRYRTAFT" whereas 
Cart-1 contains "RRHRTTFT." The 3' primer sequence is "IWFQNRR" whereas Cart-1 
contains "VWFQNRR.” Therefore, the RNase-protection assay would have eliminated up 
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to an additional 18 nucleotides (6 amino acids) from the 5' end and 21 nucleotides (7 amino 
acids) from the 3' end. Since the PAX-TS homeobox measures 174bp, subtracting an 
additional 39 nucleotides during the RNase digestion phase would yield a 135 nucleotide 
product which is in general agreement with the autoradiograph data. 
It was also shown that PAX-TS is expressed at very low levels in two normal bone 
marrow samples by RT-PCR (Figure 16). Zhao et al. did not test for Cart-1 expression in 
normal bone marrow. Therefore, unless PAX-TS is expressed ectopically in TS9;22, one 
can presume that it is expressed in some fraction of the hematopoietic cells of the bone 
marrow. As a caveat, it must be noted that Northern blot data is being compared to RT- 
PCR data which have both different sensitivities and false-positive rates. It is also possible 
that there is a small degree of "chondrocytic contamination" in the two normal bone marrow 
samples (considering that the biopsy needle must pass through bone) which would be 
detectable by PCR and not by Northern blotting. However, it is highly unlikely that there 
is any similar contamination in the TS9;22 cell line. 
Expression pattern in the CML patient whose bone marrow was the source TS9:22 
Total RNA samples from the patient whose bone marrow was the source of the 
TS9;22 cell line during the chronic phase and megakaryocytic blast crisis phase of the 
disease were obtained for RT-PCR analysis. PAX-TS expression was not detected in 
either sample even though the gene is expressed in the cell line derived from the blast crisis 
bone marrow (Figure 17). Two explanations may account for this finding. First, since we 
have already demonstrated the low level of expression in normal bone marrow, it is 
probable that PAX-TS is only expressed in a small subset of the hematopoietic cells. This 
subset may be reduced even further in the leukemic bone marrow. A comparison of the 
immunophenotype characteristics of the CML patient and the TS9;22 cell line shows that 
the relative numbers of each cell type are different (Table 3). The population of cells in 
TS9;22 are distinctly less lymphoid and more myeloid, monocytoid, and megakaryocytic 
than the patient's leukemia cells two years earlier. The fact that pelleted TS9;22 cells 
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appear pink-brown suggests hemoglobinization and some erythroid features as well 
(personal observation). The cell type which normally expresses PAX-TS may have been 
selected during establishment of the TS9;22 cell line. Second, PAX-TS may have been 
ectopically activated over baseline bone marrow levels during establishment of the cell line. 
It has been noted that mutations in the tumor suppressor gene, p53, are more frequent in 
myeloid leukemia cell lines than they are in patients with AML. This finding suggests that, 
since cells with abnormal growth characteristics are selected, alterations in oncogene 
expression may be a common feature of cell line establishment (153). Both of these 
explanations could account for the observed level of PAX-TS expression in TS9;22 relative 
to the low expression levels measured in the two bone marrow samples. 
Expression patterns of PAX-TS in rat organs 
RT-PCR expression data indicates that PAX-TS is expressed in the rat kidney 
(Figure 21). The gene was not expressed in any other organs although we did not test the 
heart, bone or central nervous system. This data is in disagreement with that of Zhao et al. 
who only found PAX-TS expression in chondrocytic cells and not in the kidney. It was 
mentioned above that "chondrocytic contamination" of the bone marrow aspirates may 
have occurred. However, for the kidney, this is highly unlikely. The appropriate controls 
were used to eliminate the possibility of genomic DNA contamination of the cDNA 
samples. Since these studies utilized RT-PCR while Zhao et al. used Northern blotting, it 
is possible that baseline PAX-TS expression in the kidney is too low for detection by 
Northern blotting, given the different sensitivities and specificities of the two methods. 
Therefore, I have concluded that PAX-TS does display some degree of renal expression. 
Expression of PAX-TS in the day 11 mouse embryo 
PAX-TS is expressed during embryogenesis. RT-PCR of total RNA from a day 11 
mouse embryo demonstrates PAX-TS expression (Figure 18). If PAX-TS is identical to 
Cart-1, this data is in agreement with Zhao et al. who demonstrate Cart-l expression in the 
developing rat embryo by Northern blotting. 
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C. IMPLICATIONS OF PAX-TS EXPRESSION DATA 
The cuiTent data indicates that the homeobox gene PAX-TS has a pattern of 
expression consistent with embryogenesis, hematopoiesis, and functional adult cells. 
Although PAX-TS may be identical to the chondrocytic Cart-1 gene, we have localized its 
expression additionally to include the kidney, bone marrow and a megakaryocytic leukemia 
cell line. If it does contain a paired domain, and becomes the ninth member of the Pax 
family, it will be of interest to explain its expression relative to the rest of the Pax genes. 
As mentioned above, the Pax family currently contains eight members (Pax 1-8). 
Human counterparts have only been named for Pax-1 (HuP48), Pax-3 (HuP2), Pax-6 
(AN), and Pax-7 (HuPl). Of the eight genes, natural mutations in Pax-1, Pax-3, Pax-6, 
and Pax-8 have been found to result in gross phenotypic anomalies in mice. Of these, the 
Pax-3 (splotch) and the Pax-6 (small eye) have human correlates (88). 
Waardenburg syndrome is inherited in an autosomal dominant fashion and is 
characterized by pigmentary disturbances, lateral displacement of the inner canthus of the 
eyes, occasional deafness, and mental retardation. The disorder has been mapped to 
chromosome 2 in the region of HuP2 and several affected families have been shown to 
carry mutations in this gene, which is homologous to Pax-3 (154, 155, 156). Aniridia is a 
congenital, bilateral panocular disorder characterized by complete or partial absence of the 
iris resulting in impaired vision. It may be associated with anomalies such as foveal and 
optic nerve hypoplasia and may deteriorate over time and result in cataracts, glaucoma, and 
comeal opacification. The incidence is rare (between 1/64000 and 1/96000) and it is 
believed to be inherited as an autosomal dominant trait (157, 158). The cDNA for Aniridia 
(AN) has been cloned and is homologous to Pax-6 which results in a similar phenotype in 
mice (159). 
It is surprising that four known mouse disorders (and two human syndromes) 
result from mutations in a family of genes which only comprises eight members. In fact 
there are no pre-existing mutants for the entire Hox gene family. Two hypotheses have 
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been offered to explain this phenomenon. First, since the Pax genes are quite large, the 
chance of mutation is increased relative to the Hox genes. Second, since the known mouse 
mutations have been shown to exhibit a dominant effect, it has been suggested that Pax 
genes are required in minimum concentrations for phenotypic expression. The loss of one 
allele could bring the concentration of the protein in the cell to below the critical threshold, 
making the mutants easily recognizable (88). This critical concentration level does not 
appear to be required for the Hox genes and, therefore, the loss of a single allele would not 
result in a phenotypic change (66, 68). It will be of interest to determine if the PAX-TS 
gene is involved in human disease. 
The oncogenic potential of the Pax genes has also been examined. Maulbecker and 
Gruss were able to induce tumor formation in mice by overexpression of the Pax-1,2, 3, 
and 8 genes. Since Pax-2 and Pax-8 contain incomplete homeodomains, they localized the 
transforming ability to the paired domain. In support of this hypothesis, they showed that 
a mutated paired domain in Pax-1 interferes with DNA binding and results in defective 
tumor formation (160). 
In support of these empiric studies, it has also been shown that Pax-3 is 
consistently involved in the t(2; 13)(q35;q 14) translocation found in the pediatric solid 
tumor, alveolar rhabdomyosarcoma (161). In this case, the chromosomal rearrangement 
fuses the 5' portion of Pax-3 with the 3' portion of the ALV gene, a member of the 
"forkhead" family of transcription factors. While the fusion protein contains an intact 
paired domain and homeodomain, the ALV DNA-binding domain is disrupted. Similar to 
the mechanism proposed for the E2A-PBX1 fusion gene, it is hypothesized that ALV 
donates an ectopic transcriptional activator to Pax-3 which incorrectly targets its action and 
enhances its ability to promote cell transformation (162). The expression of PAX-TS in a 
leukemia cell line raises the possibility that it may be involved in leukemogenesis even 
though it was not detected in the RNA samples obtained from the TS9;22 patient. 
Given its apparent expression in the rat kidney, it is important to note that PAX-TS 
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may, in fact, belong to the Pax family. Both Pax-2 and Pax-8 have been found to be 
expressed in the embryonic kidney. Pax-2 is expressed in the ureter epithelium, the 
condensing mesenchyme cells and their early epithelial derivatives. As differentiation 
occurs, the levels of Pax-2 are down-regulated. It was also shown that Pax-2 was 
expressed in elevated levels in the undifferentiated renal epithelial cells of human Wilms' 
tumor, suggesting a correlation between kidney development and down-regulation of Pax-2 
(163). Overexpression of Pax-2 in transgenic mice resulted in a histologically abnormal 
and dysfunctional renal epithelium which behaved like the congenital nephrotic syndrome. 
This data supported earlier studies in that while early development of the kidney proceeded 
normally, the epithelial maturation phase which requires down-regulation of Pax-2 was 
abnormal (164). Pax-8 has a similar expression pattern in the developing mouse kidney, 
but has also been identified in the adult kidney by Northern blotting (165). Pax-2 and Pax- 
8 are related in that they are the two members of the Pax family that contain truncated 
homeodomains which suggests a common evolutionary origin. Since PAX-TS contains a 
complete homeobox, it is not as closely related to Pax-2 and Pax-8; yet it appears to be 
expressed in the adult kidney. 
Speculations on the potential role of the PAX-TS gene in hematopoiesis 
From the immunophenotype profile, it is clear that the TS9;22 cell line contains a 
heterogeneous population of hematopoietic cells (Table 3). The large percentage (43.7%) 
of cells which express the platelet/megakaryocyte-specific antigen, CD41, classify TS9;22 
as a megakaryocytic cell line. Currently, we are unable to conclude definitively that the 
expression of PAX-TS bears any relationship to the process of megakaryocytopoiesis. In 
fact, very little is known about the unique process of megakaryocyte differentiation, from 
progenitor cell to polyploidization, at the molecular level. We were not able to demonstrate 
PAX-TS expression in another megakaryocytic cell line, MegOl. While both cell lines 
have megakaryocytic characteristics, it is impossible to compare them as representatives of 
hematopoiesis in general or megakaryocytopoiesis in particular. Rather, they serve as a 
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guide to future study. 
D. FUTURE DIRECTIONS OF STUDY 
The isolation and characterization of the cDNA and human genomic clones of PAX- 
TS will be important for several reasons. The genomic and cDNA sequences will resolve 
the identity of the human PAX-TS gene, and will determine whether it is a Pax gene or 
whether it is identical to the recently described Cart-1 homeobox gene. Then, the cDNA or 
genomic clone will be used to map the human chromosomal location of the gene. As with 
the translocation involving Pax-3 in rhabdomyosarcoma, it would be very interesting if 
PAX-TS was associated with the Philadelphia chromosome in TS9;22. 
Up to now, the lack of a cDNA or genomic clone has made PAX-TS expression 
analysis very difficult. My immediate goal is to obtain one of these clones which would 
facilitate its use as a probe for Northern blot analysis. In this way, the PAX-TS expression 
analysis in TS9;22, the normal bone marrow, and the kidney would be confirmed. 
Consideration could then be extended to include many different hematopoietic cell lines and 
RNA samples from other leukemic patients. In this way, the expression pattern of PAX- 
TS could be more accurately defined in the hematopoietic compartment. 
In order to precisely determine the hematopoietic source of PAX-TS expression it 
will be necessary to use purified normal bone marrow cells of restricted lineages. In this 
way, one could use the colony assay to screen for PAX-TS expression in single-lineage 
hematopoietic precursors. Once the "window" of expression has been narrowed, future 
studies should include antisense "knock out" assays to assess the effects of downregulation 
on hematopoiesis. Conversely, overexpression studies will provide additional data on its 
hematopoietic effects and may even suggest a role for PAX-TS as a proto-oncogene. 
Ultimately, this data will be used in order to perform both in situ hybridization studies on 
developing embryos and experiments in transgenic mice. 
E. CONCLUSION 
I have succeeded in cloning a novel homeodomain-containing gene named PAX-TS 
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from the human megakaryocytic TS9;22 cell line. The rat and mouse homologues have 
also been cloned and sequenced. Based on RNase-protection and RT-PCR data, 1 
conclude that PAX-TS is expressed in TS9;22 but not in any of the other cell lines assayed, 
including those with predominantly erythroid (MEL), myeloid (HL60, KG-1), and 
megakaryoblastic (MegOl) characteristics. RT-PCR data also demonstrates expression in 
normal bone marrow, an eleven day mouse embryo, and in the rat kidney, suggesting that, 
in addition to functioning in some hematopoietic cells, PAX-TS is expressed both during 
embryogenesis and in non-hematopoietic, adult tissues. These and future studies will help 
to elucidate how homeobox genes participate in the control of cell differentiation. 
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Figure 1: Stem Cell Model of Hematopoiesis 
Quiescent pluripotential stem cells periodically undergo a balanced, asymmetric 
mitosis. In this process, one daughter cell returns to the resting state, while the other 
becomes committed to further division and differentiation. With each subsequent division, 
the resulting progenitor cells become progessively restricted to fewer and fewer 
hematopoietic lineages. Finally, restricted progenitor cells divide to produce mature blood 


























Figure 2: Dynamics of hematopoiesis 
Throughout hematopoiesis, the characteristics of the differentiating cell population 
changes with regard to proliferative ability and surface antigen expression. The most 
primitive pluripotent cells are CD34+/CD33-/CD38-/HLA-DR- and have the capacity for 
self-renewal but proliferate at a slow rate. With the onset of hematopoiesis, these stem 
cells acquire the CD33, CD38, and HLA-DR antigens and proliferate in response to 
cytokines. This simplified view of hematopoiesis does not include the many other CD 
antigens whose expression are restricted to specific lineages. Over the course of terminal 
maturation, the capacity for proliferation declines. 
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Hematopoietic Growth Factors 
Molecular Chromosome Major Target Cells 
Growth Factor Weight (Kd) Location Source Progenitor Mature 
Erythropoietin 39 7 Kidney CFU-E Nucleated Erythroblasts 
GM-CSF 18-30 5 T-cells, monocytes, CFU-GM, -Eo Monocytes 








G-CSF 20 17 Monocytes, Fibroblasts CFU-G, -GM Neutrophils 
Endothelial cells (CFU-GEMM, -GM 
-M, at high cone.) 
M-CSF 70-90 (dimer) 5 Monocytes, Placenta, 
Endothelial cells, (human 
urine) 
CFU-M Monocytes 




IL-4 16-20 5 T-cells 
IL-5 46 (dimer) 5 T-cells CFU-Eo Eosinophils 
IL-6 19-21 7 Fibroblasts, Leukocytes, cofactor for blast 
Epithelial cells colonies 
IL-7 Leukocytes B-cells, 
Megakaryocytes 
IL-8 Leukocytes Granulocytes 
IL-9 Lymphocytes Megakaryocytes 
Table 1: Hematopoietic growth factors 
Note that, with the exception of G-CSF, the CSFs are not located on any of the 
chromosomes associated with the HOX loci (adapted from (1) and (15)). 
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Figure 3: The helix-turn-helix motif of the homeodomasn binds to 
transcription regulatory regions of DNA 
The helix-turn-helix motif binds the major groove of the DNA double helix in 
transcription regulatory regions. These structures have been confirmed by X-ray 
crystallography (adapted from (54)). 
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Figure 4: A Comparison Between Antp. and Several Families of Divergent 
Homeobox Genes 
The amino acid sequence (in single letter code) of the Antp. homeodomain is listed 
at the top of the figure. This consensus sequence contains three alpha helical regions 
separated by short turns. The most highly conserved amino acid sequence is underlined; 
the second most is double-underlined. Note that these sequences are in the alpha-helical 
regions which are vital for DNA-binding (see Figure 3). 
Schematic representations of the Antp. gene compared with some of the divergent 
homeobox genes including those containing other conserved DNA-binding motifs (Pax, 
POU, LIM, ZF families) are diagrammed in the lower half of the figure. The first ten 
amino acids in the homeobox are relatively conserved within a given divergent homeobox 
gene family. This homology was used to create the divergent homeobox primers for the 
RT-PCR assay (see Table 5). The regions corresponding to the primers are denoted with 
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Figure 5: Organization of the HOX Clusters in Humans 
The four HOX loci A, B, C, and D, are located on chromosomes 7, 17, 12, and 2, 
respectively. The current nomenclature designates the class I homeoboxes with numerals 
corresponding to their anterior-posterior position within the HOX cluster. The anterior- 
posterior designation is derived from the locations of Hox gene expression during 
Drosophila and murine embryogeneis. 
The murine equivalents are located on chromosomes 6, 11, 15, and 2. These are 
listed beneath their human counterparts. The related Drosophila genes are listed at the top 
of the figure. 
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Divergent Homeobox Genes in Hematopoietic Cells 
Gene 
Human 
Family Chromosome Known Expression in Hematopoietic Cells Reference 
HLX H2.0 1 B-lymphocytes 
Myeloid cells 
? Overexpression in some AML patients 
(104) 
HB9 HB9 1 B-lymphocytes and myeloid cells (103) 
LH-2 LIM Early B-lymphocytes 
T-lymphocytes 
(106) 
MSX-2 msh 5 Many myeloid leukemia cell lines (105) 
DLX-1 dll 2 Myeloid leukemia cell lines (KG1, F36E) (105) 
CDX/JRX cad Human T-cell leukemia cell line (Jurkat) 
Murine myeloid leukemia cell line (B6-SUT) 
(107) 
PRH(HEX) PRH (HEX) 10 Myelocytic leukemia cell line (HL60) 




GBX-1 GBX-1 7 K562 Myeloerythroblastic cell line 
Daudi B-cell line 
(111) 
Oct 11 POU Murine myeloma cell line (112) 
HOX 11 H2.0 10 Ectopically in t( 10; 14)(q24,q 11) T-cell ALL 
low levels in normal T-cells 
(117,118 
119) 
PBX-1 mat-alpha2 I Ectopically in t( 1; 19)(q23,p 13.3) B-cell ALL (121, 122 
123, 124) 
Table 2: Known Expression of Divergent Homeobox Genes in 
Hematopoietic Cells 
This table lists all the divergent homeobox genes known to be expressed in 
hematopoietic cells as of February, 1994. Each gene is presented with its family name, 







Peroxidase NEG NEG 
T-Iymphoid-associated antigens 
CDla 0.0% 0.0% 
CD2 13.5 1.7 
CD3 3.5 1.6 
CD4 85.9 8.2 
CD5 7.9 3.4 
CD7 13.7 4.3 
CD8 5.2 0.9 
CD25 51.3 25.7 
B-lymphoid-associated antigens 
CD10 2.9 5.0 
CD19 3.3 1.9 
CD20 1.6 0.0 
CD22 1.3 0.0 
Myeloid/Monocytoid-associated antigens 
CDllb 8.1 1.5 
CD13 22.7 90.8 
CD14 2.2 0.0 
CD33 88.1 98.4 
CD3 6 50.3 100.0 
Platelet/Megakaryocyte-associated antigens 
CD41 13.4 43.7 
CD42b 2.3 0.0 
Others 
CD56 0.9 0.0 
CD57 0.3 
HLA-DR 8.7 92.7 
CD34 29.1 
Table 3: Immunophenotype of the CML patient (during accelerated phase 
of CML in 1991) and of the TS9;22 cell line derived from this patient's 
bone marrow cells during megakaryocytic blast crisis. 
The numbers for each cell surface characteristic represent the percentage of cells 
assayed which expressed the antigen. The presence or absence of peroxidase activity was 
also assayed. These data provided by Dr. K. Ohyashiki, Tokyo Medical College, Tokyo, 




cDNA templates RNA templates cDNA templates 
class I primers class I primers 62- primers 
180bp 
Figure 6: Identification of Homeobox Expression in Four Leukemia Cell Lines. 
3% agarose gel of the initial PCR experiment in which TS9;22, ES, KG1, and 
MEL cDNAs (Lanes 2-5) and DNased poly-A+-mRNAs (Lanes 6-9) were tested with the 
5'-class I homeobox primer (2551). 62-microglobulin was used as a cDNA control 
(Lanes 10-13). The murine-derived ES and MEL cDNAs do not yield the appropriate 
PCR signal with the B2-microglobulin primers because of mismatches in the DNA 
sequence of the primer which is based on the human sequence (Lanes 11, 13). The 
template for lane 14 is a plasmid with a known class I homeobox sequence. 
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Leukemia Cell Lines 
Cell Line Name Source Reference 
ES Embryonic Stem Cell Pluripotent cell line derived 
from murine blatocyst cells 
(133) 
KG-1 Myeloblastic cell line derived 
from a patient with AML 
(130) 
TS9;22 Japanese patient with CML 





MEL Mouse erythroleukemia Murine erythroid cell line (134) 
HL60 Myeloid cell line derived 
from a patient with AML 
type M2 
(131) 
MegOl Megakaryoblastic cell line 
derived from a patient with 
CML in blast crisis 
(132) 
Table 4: Cell Lines Used for RT-PCR Assays 
These cell lines contain transformed hematopoietic cells representing the myeloid, 
erythroid, and megakaryocytic lineages. The ES cells are not hematopoietic cells but are 
pluripotent and may be induced to differentiate into many, if not all, tissue-types. 
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Primer Sequence^ Reference 
3067 chox3 .TAFTYEQL ACIGCITT(CT)ACITA(CT)GA(AG)CA 
(AG)CT 
3066 Hox7.1/msh .RKPRTPFT.... (CA)GIAA(GA)GIACICCITT(TC)AC (141,142) 
3582 LIM .RGPRTTI. (CA)GIGGICCI(CA)GIACIACIAT (166) 
3583 H2.0 .SWSRAVF. (AT)(GC)ITGG(AT)(GC)I(CA)GIGCI 
TITT (167) 
3689 dll .RKPRTIY. (CA)GIAA(GA)CCI(CA)GIACIAT(ACT) 
TA (168) 
3690 ceh 5 .KRPRTDN. AA(GA)(CA)GICCI(CA)GIACIGA(CT)AA (169) 





3692 ceh 7 .PRRRTTF. Cl(CA)GI(CA)GI(CA)GIACIACITT (59) 




3694 cut AA(GA)AA(GA)CA(GA)(CA)GIGTICTITT (172) 
3695 htr .KRTRTAY. AA(GA)(CA)GIACI(CA)GIACIGCITA 
3696 NK 4 KRKPRVLF. AA(GA)(CA)GIAA(GA)CCI(CA)GIGTICT 
ITT (170) 
3697 isl .TRVRTVL. ACI(CA)GIGT(CA)GIACIGTICT (166) 
3763 NK 3 .KRSRAVF. AA(GA)(CA)GI(AT)(GC)I(CA)GIGCIGC 
ITT (170) 
3765 chox 1 .GSLRTSF. GGI(TA)(CG)I(CT)TI(CA)GIACI(TA) 
(CG)ITT 
(173) 
3766 xhox 3/eve .RRYRTAFT.... GI(CA)GITA(TC)(CA)GIACIGCITT(CT) 
AC (143 , 144) 
3767 ceh 3 .DKYRMVY. GA(CT)AA(GA)TA(TC)(CA)GIATGGTITA (169) 
3768 zen 2 .KRSRTAF. AA(GA)(CA)GI(TA)(GC)I(CA)GIACIGC 
ITT 
3769 e4e5/ems .KRVRTAF. 
I 
AA(GA)(CA)GI(GA)TI(CA)GIACIGCITT (174) 




(adapted from (84)) 
1 "Gene Family" indicates a representative member of the divergent gene family 
2 "Amino Acid Sequence" is the first ten amino acids of the homeobox sequence 
characteristic of the divergent homeobox gene family. Amino acids not represented in the 
primer are depicted with a period (.). In some cases, there is degeneracy in the amino acid 
sequence of a divergent gene family. 
3 All the primers used here are preceded by the sequence, GCGAATTC, which contains 
the restriction site for EcoRI at the 5' end in order to facilitate subcloning of the PCR 
fragment. 
4 This seven amino acid sequence is conserved in most of the class I homeobox genes. 
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Figure 7: Screening of TS9;22 cDNA With Divergent Homeobox Primers 
Ethidium stain of 3% agarose gels containing the PCR products from TS9;22 
cDNA using degenerate oligonucleotide primers shown in Table 5. A positive signal was 
generated with the class I, msh, and xhox/eve primers (Lanes 2 and 13, 4, 21, 
respectively). Lanes 11 and 24 contain a class I homeobox "positive control" plasmid. 
Note that the msh and xhox/eve PCR fragments are larger than the class I-derived 
fragments, reflecting the more 5' position of the divergent primers within the homeobox 
for this set. "Size marker" indicates the MspI digest of plasmid pBR322. 
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Primer Result (+/-) 




















Table 6: Summary of RT-PCR Screening of TS9;22. 
Summary of RT-PCR screening of the TS9;22 cell line with 19 divergent 
horneobox primers shown in Table 5. A "+" indicates that an appropriate sized PCR 










xhox/eve primer (3766) 







C C CAGGTTTAG TC CAAGG TTT TATTGGG3TTAAG A3GTCT 
JAATTC PGCAGA 
135 
conserved 3' homeobox primer (2552) I 
174 
V Q I W N R R 
Figure 8: Sequence of PAX-TS RT-PCR Clone 
DNA nucleotide sequence of the PAX-TS homeobox clone. The degenerate primer 
regions are underlined with the EcoRI cloning sites boxed. The deduced amino acid 
sequence is listed below in single letter code. 
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Comparison of Cloned TS9;22 Homeoboxes with Published Amino Acid Sequences 
Primers Used Sequence Homology 
(%) 
1) Class I (2551) elekeflfnmyltrdrrhevarllnlserqvkiwfqnrr 
HQX B9 - 100 





3) xhox 3/eve (3766) human 
Cart-1 (rat) 
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Figure 9: Amino Acid Sequences of Cloned TS9;22 Homeobox Genes and 
Comparison to Other Known Homeodomains 
The three homeoboxes cloned from TS9;22 derive from HOX B9, MSX-2, and a 
previously unidentified gene. A Genbank search revealed that the amino acid sequence of 
this homeobox is identical to the rat Cart-l gene. It also bears close resemblance to the 
"paired-like" genes including smox-3 and Pax-7 and shares significant homology with 
several other divergent homeobox genes (151). 
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Figure 10: Amino Acid Sequence Deduced from the Nucleotide Sequence 
of the Cloned PCR Products from Figure 9 
Amino acids are in single letter code. Lower case letters represent the PCR primer 
sequences. Capital letters represent the cloned peptide sequence within PCR primers. 




260bp (predicted length) product of A+B = positive control 
► 
B = 296bp cold, sense Hindlll runoff transcript 
A = 290bp radiolabelled, antisense Xhol runoff transcript 
Hindlll Xhol 
Figure 11: TA Cloning Vector Containing the 174bp TS9;22 PCR Product 
TA Cloning vector containing the 174bp RT-PCR product using TS9;22 first- 
strand cDNA as template and primers 3766 and 2552 (xhox3/eve family). The orientation 
of the coding sequence of the insert within the plasmid is shown with an arrow. The 
enlarged view of the multiple cloning site and the PCR insert shows the two promoters and 
restriction sites used to generate the radiolabeled antisense (A) and cold sense (B) RNA 
transcripts used in the RNase-protection assay. The orientation of both transcripts and the 
two RNase-protection products are depicted above. The dotted lines at the ends of the 
RNase-protection product indicates the potential for mismatches between the degenerate 
primer and the true gene sequence. 
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Figure 12: RNase-protection Assay to Determine PAX-TS Expression in the 
TS9;22, HL60, MegOl, KG1, and MEL Cell Lines 
PAX-TS-specific, radiolabelled antisense RNA was hybridized to the total RNA 
samples indicated, digested with ribonuclease and electrophoresed. Lane 1 contains the 
290bp radiolabelled "antisense" transcript. Lane 2 contains the positive control RNase- 
protection product of the radiolabelled "antisense" transcript and a cold sense transcript. 
Lane 3 contains the negative control product of the radiolabeled RNA probe and sterile 
water as a template. Lanes 4-8 contain the RNase-protection products of the radiolabeled 
"antisense" probe and total RNA from the five cell lines. Only TS9;22 demonstrates 
PAX-TS expression. See Figure 11 for the predicted fragment sizes. Note that the RNA 
products run faster on the gel than DNA fragments of similar length. Thus, the apparent 








174bp PAX-TS Homeobox Clone 
TS-1 - TGCAGCTAGAGGAGCTGGAG 
TS-2 - GCTAGAGGAGCTGGAGAAAG 
TS-3 - GATGTGTATGTCAGAGAACA 
TS-4 - TGAGGACAGAGCTCACTGAG 
TS-RA - CTGGGACCGGAGTCACTCG 
TS-RB - CAGTGAGCTCTGTCCTCAG 
Figure 13: PAX-TS Primers Listed in This Thesis 
The six primers shown above are specific for the human PAX-TS homeobox and 
are based on the sequence data of Figure 8. The rightward arrows indicate primers 
corresponding to the top strand (as in Figure 8) while the leftward arrows indicate the 
lower strand. TS-1 and TS-RA were used in the majority of the RT-PCR assays. TS-3 
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Figure 14: RT-PCR Assay for PAX-TS Expression in the TS9;22 and 
MegOl Cell Lines 
The TS9;22 and MegOl cell lines were screened for PAX-TS expression by the 
RT-PCR assay. The screening for each of the two cell lines includes total RNA, DNased 
total RNA, and first-strand cDNA. 82-microglobulin- (82) and DLX-specific primers were 
used as positive cDNA controls. A human genomic DNA template was used for 
comparison (Lanes 2-4). The 104bp PAX-TS band was only present in the human 






Figure 15: PAX-TS Expression Determined by RT-PCR Analysis Followed 
by Southern blot 
The left panel contains the ethidium-stained gels of the PCR products generated 
using cDNA templates synthesized from TS9;22, MegOl, HL60, and KG1 and assayed for 
PAX-TS and 62-microglobulin (62) expression. Human genomic DNA was used as a 
positive control (Lane 6, above). The right panel shows a Southern blot of the gels on the 





Figure 16: PAX-TS Expression in Normal Bone Marrow 
RT-PCR analysis was performed on RNA samples obtained from normal bone 
marrow cells. The upper left panel contains the ethidium-stained gels of the RT-PCR assay 
for PAX-TS expression in two healthy human bone marrow samples. 132-microglobulin 
(132) serves as a comparison of the cDNA templates (lower left). The right panel contains 
the Southern blot using the radiolabeled TS-3 or 132 oligonucleotides as probes. 
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Figure 17: RT-PCR Analysis of TS9;22, Chronic Phase CML, and Megakaryocytic 
Blast Crisis RNA 
The left panel contains the ethidium-stained gel of RT-PCR analysis of TS9;22, 
chronic phase CML, and megakaryocytic blast crisis total RNA. The right panel contains 
the Southern blot of this gel. Lanes 1-3 are the DNased total RNA samples; lanes 4-6 are 
the first strand oligo-dT cDNA samples. 
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Figure 18: PAX-TS Expression in the 11 Day Mouse Embryo 
Ethidium-gel of RT-PCR of 11 day mouse embryo total RNA. cDNA was 
synthesized from day 11 mouse embryo total RNA and used for PCR analysis. HPRTase 
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Figure 19: A Comparison of Mouse and Human Genomic DNA Templates for PCR 
Using Human PAX-TS-Specific primers 
The left panel shows the ethidium-stained gel of the PCR analysis of human 
(Lanes 2-5) and mouse (Lanes 6-9) genomic DNA templates using the four primer pairs: 
TS-1 and TS-RA, TS-1 and TS-RB" TS-2 and TS-RA, and TS-2 and TS-RB. Refer to 
Figure # for information on the PAX-TS-specific primers. The right panel contains the 
Southern blot using the radiolabeled TS-3 oligonucleotide as a probe. Although theTS-3 
probe did not hybridize to the murine PCR products, these bands were confirmed as 
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Figure 21: PAX-TS Expression in Rat Organs by RT-PCR Analysis 
In the left panel, the ethidium-stained gel contains the RT-PCR products from RNA 
extracted from the organs of an adult rat. Total RNA was extracted from lung, stomach, 
small bowel, large bowel, spleen, liver, kidney and skeletal muscle and PCR analysis was 
performed with the PAX-TS specific primers, TS-1 and TS-RA. The PCR products from 
the DNased total RNA are in the upper row (Lanes 2-11) and the products from the first- 
strand cDNA samples are in the lower row (Lanes 13-22). TS9;22 and MegOl served as 
positive and negative controls, respectively (Lanes 2 + 3, and 13 + 14). In the rat organ 
systems tested, only the kidney demonstrates PAX-TS expression. On the accompanying 
Southern blot, only the TS9;22 PCR product hybridized to the probe. The rat kidney 
fragment does not hybridize under the wash conditions of this Southern blot, suggesting 
that there is some mismatch in the rat compared to the human sequence in the region of the 
radiolabelled oligonucleotide. This fragment was confirmed as PAX-TS by direct cloning 
and sequencing (see Figure 20). 
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Figure 22: Restriction Digest of the PI Phagemid Containing a ~70kb 
PAX-TS Insert 
Ethidium-stained gel of restriction digests of the PI phagemid with and without a genomic 
insert. Lane 1 contains the uncut PI phage vector. Lanes 2-4 contain the PI phage vector 
digested with Hindlll, BamHI, and EcoRI. Lane 5 contains the uncut PI phagemid clone 
carrying the ~70kb PAX-TS genomic insert. Lanes 6-8 contain the PI phagemid PAX-TS 
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Figure 23: PI Southern Blot of PI Phagemid Clone Carrying the PAX-TS Genomic 
Sequence 
The Southern blot of the PI phagemid restriction digest using the radiolabel led TS- 
3 oligonucleotide as a probe. Lanes 2-5 contain the uncut and digested control PI 
phagemid without insert. Lane 6 contains the uncut PI phagemid carrying the genomic 
insert. Lanes 7, 8, and 9 depict the ~8kb, ~5kb, and ~ lOkb fragments containing the PAX- 
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Figure 24: Secondary PCR screening of PI genomic phage mini-library 
Fourteen plates containing 50 phage each were screened by the PCR assay using the PAX- 
TS-specific primers, TS-1 and TS-RA, after elution into SM buffer. Lane 11 contains the 

















Figure 25: A Comparison of the Nucleotide Sequences of the PAX-TS and 
Cart-1 Homeoboxes 
There is 84% homology between Cart-1 and PAX-TS. However, most of the 
mismatches occur in the regions of the two degenerate primers (underlined) which may not 
reflect the actual gene sequence. All of the other mismatches are conservative such that the 
amino acid sequences are identical. 
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